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ABSTRACT OF THE DISSERTATION 
 
Avoidance in Fear Conditioning and Anxiety Disorders 
 
by 
 
Bita Mesri 
Doctor of Philosophy in Psychology 
University of California, Los Angeles, 2019 
Professor Michelle G. Craske, Chair  
 
 
 This dissertation is a three-paper investigation of ways to improve treatment outcomes for 
anxiety disorders.  
 Study 1 investigates whether training implicit approach or avoidance to feared stimuli 
augments or impedes fear extinction. We also investigate whether baseline explicit avoidance 
predicts extinction performance or future avoidance behavior. Extinction performance is used as 
a proxy for exposure therapy. Results revealed no effect of training implicit approach or 
avoidance on extinction performance nor future behavioral avoidance. Baseline explicit 
avoidance did not predict extinction performance, whereas it did predict future behavioral 
avoidance. Findings suggest that explicit avoidance may not affect fear extinction in an 
unambiguous fear-conditioning paradigm, but that it may affect future tendency to approach 
feared stimuli. 
 
iii	  
Study 2 investigates behavioral avoidance as a moderator of treatment outcome for two 
behavioral therapies for social anxiety disorder. Individuals who were highly behaviorally 
avoidant on a public speaking task had better long-term treatment outcomes following cognitive 
behavioral therapy (CBT) than acceptance and commitment therapy. From a deficit correction 
model, individuals who are more behaviorally avoidant may benefit from a treatment that more 
systematically targets that avoidance. A version of this work has been published in the Journal of 
Behavior Therapy and Experimental Psychiatry (2017). 
Study 3 investigates interoceptive and in vivo avoidance as moderators of treatment 
outcome for two different CBTs for panic disorder. Individuals who displayed more in vivo 
avoidance at baseline had better outcome following CBT with interoceptive exposures than CBT 
with interoceptive and in vivo exposures. This suggests that avoidant individuals benefit more 
from a therapy that targets their primary interoceptive concerns as opposed to one that expands 
to in vivo avoidance. 
Taken together, these studies aim to improve treatment outcomes in behavioral therapies 
for anxiety disorders. Study 1 suggests that retraining implicit approach avoidance behavior does 
not augment fear extinction in an unambiguous fear conditioning design. Studies 2 and 3 suggest 
that individuals with anxiety disorders who are highly avoidant at baseline may benefit from 
treatments that explicitly target their primary avoidance. This line of research can provide 
evidence-based methods for treatment selection to better match individuals to specific therapies. 
Additionally, all three studies contribute to our understanding of implicit and explicit avoidance 
in fear and anxiety. 
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DISSERTATION INTRODUCTION
Anxiety disorders are the most prevalent psychological disorders, affecting 
approximately one third of adult Americans (Kessler et al., 2005; Kessler, Petukhova, Sampson, 
Zaslavsky, & Wittchen, 2012). These disorders are associated with significant distress and 
functional impairment (Olatunji, Cisler, & Tolin, 2007). Left untreated, anxiety disorders can 
lead to the development of other psychological disorders including mood and substance use 
disorders (Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Zahradnik & Stewart, 2009). 
Exposure-based treatments such as cognitive behavioral therapy (CBT) are among the most 
empirically supported treatments for anxiety (Barlow, 2002; Norton & Price, 2007). Yet, 
response rates to CBT are approximately 50%, making improvements for treatment response 
necessary (Loerinc et al., 2015).  
Susceptibility to fear conditioning and deficits in extinction are believed to contribute to 
the onset and maintenance, respectively, of excessive and impairing anxiety (Barlow, 2002; 
Lerman, 2003). In aversive classical conditioning, fear is acquired when a neutral conditional 
stimulus (CS) is repeatedly paired with an innately aversive unconditional stimulus (US). As a 
result of this repeated pairing, the CS comes to predict the US, eliciting a conditional fear 
response (CR). Fear is extinguished by presenting the CS numerous times in the absence of the 
US.  
In 1913, Bechterev conducted the first experiment documenting an avoidance response to 
aversive stimuli. He followed a neutral CS with an electric shock (US) to dogs’ paws. When the 
CS was later presented, the dogs moved their paws to avoid the shock. Classical conditioning 
explains the learned fear of a CS, but fails to explain this learned avoidance behavior. In classical 
2 
conditioning, participants’ behaviors do not affect whether or not they receive the US, whereas in 
this learned avoidance behavior, moving their paws affects whether they receive the shock 
(Herrnstein, 1969).   
 Soon, experiments were conducted that included both classical conditioning and an 
explicit avoidance procedure (Brogden, Lipman, & Culler, 1938; Solomon, Kamin, & Wynne, 
1953). Solomon, Kamin, and Wynne (1953) placed dogs in chambers that were divided by a 
short barrier into two compartments. A light (CS) signaled the administration of electric shocks 
(US) in one compartment of the chamber. After a few trials, the dogs learned that the light 
predicted the shock and would jump over the barrier to avoid the shock. Instrumental 
conditioning was used to explain this avoidance response. In instrumental conditioning, 
individuals are motivated to engage in certain behaviors through reward and punishment. In this 
case, avoidance behavior was thought to be negatively reinforced by the removal of the aversive 
stimulus. However, instrumental learning could not be used to explain how the absence of 
something was reinforcing.  
Mowrer’s two-factor theory of fear and avoidance (1947) attempted to explain avoidance 
behavior by combining fear conditioning and operant conditioning. The first factor of Mowrer’s 
theory was that fear of a neutral stimulus can be learned through classical conditioning. Through 
repeated pairing with a US, a neutral stimulus (CS) evokes fear. The second factor was that 
avoidance of a CS is learned through operant conditioning. The avoidance behavior (e.g., 
moving paw, jumping barrier) is learned through negative reinforcement because the avoidance 
behavior ends the feared CS. This component filled the previous gap because Mowrer explained 
avoidance behavior in terms of escape from a CS rather than in terms of prevention of US. This 
theory was seminal in the creation of exposure-based treatments for anxiety. Nevertheless, the 
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theory fails to explain some other features of avoidance learning (Herrnstein, 1969). First, 
avoidant responding can be learned even if the response does not terminate the CS or reduce the 
duration of CS, so long as the response prevents the US (Bolles, Stokes, & Younger, 1966; 
Soltysik, Wolfe, Nicholas, Wilson, & Garcia-Sanchez, 1983). Second, avoidance behaviors can 
be taught without a CS if the avoidance behavior simply reduces the frequency of the US 
(Herrnstein & Hineline, 1966). Third, if a CS can be followed by an avoidance response, 
individuals report less fear of the CS (Lovibond, Saunders, Weidemann, & Mitchell, 2008; 
Mineka, 1979; Solomon, Kamin, & Wynne, 1953). This is problematic because Mowrer’s theory 
hinges on the CS being a feared stimulus.  
The safety signal theory of avoidance was created in response to the shortcomings of 
Mowrer’s theory (Gray, 1975; Hammond, 1967). In Mowrer’s two-factor theory, avoidance 
behavior was motivated by negative reinforcement through the removal of a feared CS. In the 
safety signal theory, avoidance is motivated by positive reinforcement through the addition of 
positive feedback related to feeling safe (Rachman, 1984). This explains why avoidance 
responses can be learned even if they do not affect the duration or the occurrence of the CS. It 
also explains why people’s fears of the CS are reduced when they learn an avoidance behavior.  
The safety signal theory of avoidance also helps explain why avoidance impedes fear 
extinction. In the previously explained experiment by Solomon, Kamin, and Wynne (1953) in 
which dogs jumped over barriers to avoid shocks, one of the dogs engaged in the avoidance 
behavior on 650 successive trials after only receiving a few shocks. The persistence of this 
avoidance response was found even after the experimenter had unplugged the shock device. 
Dogs continue to engage in the avoidance behavior because they are motivated to receive the 
safety feedback. By continuously performing the avoidance response, they associate any safety 
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to the avoidance response rather than the situation. This prevents the participant from learning 
that the cage is no longer wired to provide shocks.  
An alternative explanation to avoidance impeding extinction can be derived from the 
Rescorla-Wagner (1972) model. This model theorizes that learning increases as the discrepancy 
between what is expected to occur and what actually occurs increases. No learning occurs when 
what is expected matches what occurs. In a fear-conditioning model in which the presence of a 
tone (CS) precedes an unexpected shock (US), animals have the greatest fear learning after the 
first few shocks. As the tone is continuously paired with the shock, the animals continue to 
associate the tone with fear, but at a slower pace of learning. With enough pairing, the animals 
expect the shock to follow the tone and no new learning occurs across subsequent trials. Fear 
extinction occurs when the tone, which is expected to cue the shock, is no longer paired with the 
shock. Through the discrepancy between expecting a shock and not receiving a shock, the 
animals learn that the tone is no longer predictive of shock and fear extinguishes.  
During the extinction phase, if the avoidance behavior is performed, there is no discrepancy 
between what is expected and what actually occurs, so there is no learning. Because the animal 
continues with the old learning that the CS is predictive of the US, the animal will continue to 
fear the CS even if it is no longer actually paired with the US.  
Seligman and Johnston’s “cognitive theory of avoidance learning” (1973) also relies on 
the idea that learning occurs during expectancy violations. Their theory highlights that cognitions 
related to expectations mediate this learning. Humans or animals learn to expect an aversive 
stimulus if an avoidance response is not performed and they learn not to expect the aversive 
stimulus if an avoidance response is performed. This theory expands on previous ones by 
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explaining how individuals can acquire a fear of CS after simply being informed that a specific 
CS predicts a US (informational transmission; Kirsch, Lynn, Vigorito, & Miller, 2004). 
Lovibond’s (2006) expectancy model expands on Seligman and Johnston’s cognitive 
theory by theorizing that fear acquisition includes both implicit (i.e., unconscious, reflexive) and 
explicit (i.e., conscious) components. In this model, during fear acquisition, the CS elicits fear 
through both implicit (e.g., Pavlovian) learning and explicit (e.g., cognitive) expectation that the 
CS predicts the US. During extinction learning, individuals use their explicit outcome 
expectations to decide whether to respond in avoidance or not. In Lovibond’s theory, anxiety 
affects the expectancy of the aversive outcome, which in turn affects avoidance behavior. 
Avoidance behavior then impedes extinction by preventing individuals from learning that the CS 
no longer predicts the US (Lovibond, Mitchell, Minard, Brady, & Menzies, 2009). 
Cognitive models of anxiety posit that individuals with anxiety think differently from 
healthy controls. Compared to non-anxious individuals, anxious individuals demonstrate 
irrational or excessive threat appraisals, which result in exaggerated beliefs about the probability 
and distress of an aversive outcome (Butler & Mathews, 1987; Rachman, 1994). By being 
exposed to situations that they previously avoided, individuals are able to learn that they often 
over-predict the probability and distress of an aversive outcome. However, mere exposure to a 
feared situation may not be enough to disconfirm false beliefs if individuals use covert methods 
of avoidance such as “response aids” or “within situations safety behaviors” (Bandura, Jeffery, & 
Wright, 1974; Salkovskis, 1991). 
 Safety behaviors are subtle behaviors or even thoughts used to avert a feared outcome 
(Salkovskis, 1991). The use of safety behaviors explain why an individual with panic disorder 
who has had over 30 panic attacks that did not end in fainting still fears fainting. If the individual 
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is engaging in a safety behavior such as taking an anxiolytic or sitting down, the individual 
learns that the safety behavior prevented fainting instead of learning that panic attacks do not 
cause fainting. The individual attributes safety to the safety behavior rather than the feared 
situation. Just like overt avoidance, which was previously discussed in the “safety signal theory 
of avoidance,” covert avoidance in the form of safety behaviors prevents exposure learning or 
fear extinction (Salkovskis, 1991). Despite the overwhelming literature supporting dropping 
safety behaviors during exposure therapy, there are a few studies that find comparable outcomes 
between exposures with and without safety behaviors (Milosevic & Radomsky, 2008; Piccirillo, 
et al., 2016; Rachman, Craske, Tallman, & Solyom, 1986). This has prompted some to suggest 
that the judicious use of safety behaviors at the beginning of exposure therapy or in situations of 
extreme fear may be harmless (Rachman, Radomsky, & Shafran, 2008). In these studies, safety 
behaviors were used sparingly. Conceivably, the overall benefit of exposure therapy may have 
overshadowed the early use of safety behaviors.    
Overt and covert avoidance are key features across many anxiety disorders making them 
potential transdiagnostic maintenance factors (Barlow, 2002).  
Panic disorder  
Individuals with panic disorder are overly concerned about the consequences of having a 
panic attack (American Psychiatric Association, 2013). They may worry that a panic attack will 
lead to fainting, having a heart attack, dying, or going crazy (American Psychiatric Association, 
2013). In the previous panic disorder example, individuals may avoid situations that may 
increase their heart rate such as going to the gym or taking a hot shower. They may fear that an 
increase in heart rate may induce a panic attack and lead to fainting. Safety signals may include 
taking an anxiolytic or sitting down when noticing an increased heart rate (Helbig-Lang et al., 
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2014). These avoidance strategies are problematic in that they block the ability to learn that a 
panic attack does not actually lead to fainting or death (Salkovskis, Clark, & Gelder, 1996). 
Additionally, avoidance of many different situations can affect the quality of life of an individual 
who may no longer be able to engage in everyday activities such as exercise. Indirect evidence 
for the maintenance roles of safety behaviors and avoidance of panic disorder is found through 
short and long-term reductions in panic anxiety following exposure treatments that encourage 
giving up safety behaviors (Clark et al., 1994).  
Agoraphobia  
Individuals with agoraphobia have a fear of being in a situation where they may not be 
able to escape if they have a panic attack (American Psychiatric Association, 2013). Commonly 
avoided situations include shopping malls, subway stations, or concerts (American Psychiatric 
Association, 2013). In severe cases, individuals may be unable to leave their home.    
Safety behaviors may include locating all exits before entering a room, staying near an exit, or 
only entering situations if a friend is present to ensure safety (Rachman, 1984). Exposure therapy 
accompanied with dropping safety behaviors and belief disconfirmation strategies have been 
found to be more effective than habituation-based exposure therapies for agoraphobia 
(Salkovskis et al., 2007). Even a single exposure with instructions to drop safety behaviors led to 
significant improvements in agoraphobic symptoms compared to exposures without instructions 
to drop safety behaviors (Salkovskis, Clark, Hackmann, Wells, & Gelder, 1999).  
Social Anxiety Disorder 
Individuals with social anxiety disorder fear being negatively judged, rejected, or 
humiliated (American Psychiatric Association, 2013). Overt avoidance may take the form of 
completely avoiding social situations (e.g., parties, meetings). Individuals with social anxiety 
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may select socially isolating jobs (e.g., truck driver) and may avoid in-person interactions as 
much as possible (e.g., get groceries delivered to their house). When forced to have a social 
interaction, they may use safety behaviors such as avoiding eye contact or responding with short 
answers, believing that these behaviors may lessen their chances of being rejected (Wells et al., 
1995). Paradoxically, these safety behaviors, which are meant to decrease rejection, may actually 
increase rejection (Alden & Bieling, 1998). For example, the person who avoids eye contact may 
be seen as aloof or cold. In addition to explicit avoidance, individuals with social anxiety 
disorder demonstrate implicit avoidance tendencies toward crowds with angry faces (Lange, 
Keijsers, Becker, & Rinck, 2008). There is overwhelming evidence that exposure therapy and 
CBT with specific instructions to drop safety behaviors have better long-term outcomes than 
treatments that do not instruct individuals to drop safety behaviors (for a review, see Piccirillo, 
Dryman, & Heimberg, 2016). 
Specific Phobia  
Individuals with specific phobias have intense persistent fears of one specific situation, 
animal, or object (American Psychiatric Association, 2013). Often, specific phobias fall into one 
of the following categories: animals (e.g., spiders, dogs), natural environments (e.g., heights), 
blood/ injury/ injections (e.g., getting a shot), or situations (e.g., airplane, elevators) (American 
Psychiatric Association, 2013). An example of overt avoidance is an individual with a specific 
phobia of heights who avoids hiking. An example of a safety behavior may be going hiking, but 
staying extremely far from the edge, believing that getting too close will lead to death. In 
addition to explicit avoidance, individuals with a specific phobia of spiders were found to 
demonstrate implicit avoidance tendencies to images of spiders (Rinck & Becker, 2007). 
Individuals with claustrophobia who were randomized to exposures with explicit instructions to 
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focus/ reappraise threat or drop safety behaviors, fared better than individuals who were given 
the option of using safety strategies (Sloan & Telch, 2002). In a follow-up study, Powers, Smits, 
and Telch (2004) randomized individuals with claustrophobia to one of five groups: 1. Exposure 
only, 2. Exposure with safety behavior availability, 3. Exposure with safety behavior utilization, 
4. Credible placebo treatment, and 5. Waitlist. Response rates were 94%, 45%, 44%, 25%, and 
0% respectively, pointing to the superiority of exposures without safety behaviors. Likewise, in 
height and driving phobics, Williams, Dooseman, and Kleifield (1984) found that exposure 
therapy combined with fading safety behaviors was more effective than exposure alone.  
Generalized Anxiety Disorder (GAD) 
Individuals with GAD spend most of their day worrying about many different topics such 
as finances, family, health, or work (American Psychiatric Association, 2013). GAD is the only 
anxiety disorder that is not categorized by behavioral avoidance in the DSM-5 (American 
Psychiatric Association, 2013). This may be because fears in GAD are often future-oriented or 
not tangible (e.g., fearing that your child will die), making it difficult to identify behavioral 
avoidance. Additionally, fear and avoidance are more heterogeneous in a sample of GAD as 
opposed to one of claustrophobia. For example, an individual with GAD who is worried about 
future finances may avoid opening bills, whereas one who is worried about future health may 
avoid going to the doctor. General avoidance behaviors that have been found across individuals 
with GAD include checking as a form of reassurance seeking, making lists, and avoiding making 
decisions (Beesdo-Baum et al., 2012). It is theorized that the act of worrying itself is a form of 
cognitive avoidance aimed at reducing emotionality triggered by a previous thought (Borkovec, 
Alcaine, & Behar, 2004; Schut, Castonguay, & Borkovec, 2001). There is some evidence that 
behavioral avoidance somewhat decreases after treatment for GAD (Beesdo-Baum et al., 2012). 
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Additionally, there is evidence that high degrees of behavioral avoidance and safety behaviors 
following treatment predict poor long-term treatment outcomes (Beesdo-Baum et al., 2012). 
More research on behavioral avoidance and safety behaviors in GAD is necessary (Mahoney et 
al., 2016). 
Post Traumatic Stress Disorder (PTSD) 
 PTSD is a disorder that develops after an individual has experienced a traumatic incident 
such as sexual assault or warfare (American Psychiatric Association, 2013). It is no longer part 
of the DSM-5 Anxiety Disorders, but it is considered an affective disorder marked with high 
negative affect (DiMauro, Renshaw, & Kashdan, 2016; Ehlers & Clark, 2000). Symptoms of 
PTSD include mental avoidance or behavioral avoidance of places, situations, or cues that 
remind the individual of the traumatic incident (American Psychiatric Association, 2013). This 
avoidance is thought to, at least partially, maintain the disorder (Bryant & Harvey, 1995; 
Dunmore, Clark, & Ehlers, 2001; Feeny & Foa, 2006). Moreover, in addition to explicit 
avoidance, individuals with PTSD have been found to have greater implicit avoidance of high 
threat images compared to healthy controls (Fleurkens, Rinck, & van Minnen, 2014). Indirect 
evidence for the role of avoidance in maintaining PTSD is evident from the positive response to 
prolonged exposure treatment (Cusack et al., 2016; Nacasch et al., 2011; Steenkamp, Litz, Hoge, 
& Marmar, 2015).  
Conclusion 
Overt and covert avoidance are important transdiagnostic factors in the onset and 
maintenance of anxiety disorders. Across a set of three studies, we aim to use our understanding 
of avoidance to improve treatment outcomes for anxiety disorder. Study 1 investigates whether 
retraining implicit approach/ avoidance tendencies toward feared images enhances or hinders the 
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process of fear extinction. Uncovering methods that improves fear extinction can then potentially 
be used to augment exposure therapy, an essential treatment for anxiety disorders. Studies 2 and 
3 investigate whether individuals with high baseline avoidance fare better in one of two 
treatments for anxiety disorders. Better matching individuals to treatments has the potential to 
enhance treatment effectiveness.   
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Study 1 
 
Baseline Characteristics as Predictors of Fear Acquisition, Extinction,  
and a Behavioral Forced Choice Test 
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Abstract 
Background and Objectives: Susceptibility to fear conditioning and deficits in extinction are 
believed to contribute to the onset and maintenance, respectively, of excessive and impairing 
anxiety. Avoidance of fear stimuli is thought to impede fear extinction. This study aims to 
investigate whether training implicit approach or avoidance to fear stimuli affects fear extinction 
and overt avoidance behavior. Additionally, we aim to increase our wealth of knowledge of 
baseline characteristics that predict fear acquisition, extinction, and overt avoidance behavior.  
Methods: Participants (N = 135) were assessed at baseline for explicit avoidance, state anxiety, 
and trait anxiety. They underwent differential fear conditioning during which they acquired fear 
of one stimulus (CS+) and not of another stimulus (CS-). Participants were then randomized to 
one of four groups, wherein they received implicit approach training to the CS+, avoidance 
training to the CS+, 50-50 training, or no training. This was followed by fear extinction during 
which neither stimulus was paired with an aversive unconditional stimulus. A behavioral forced-
choice test was used to measure overt behavioral avoidance of fear stimuli. 
Results: There was no significant effect of group assignment on extinction performance or overt 
avoidance behavior. State anxiety and explicit avoidance predicted overt approach behavior to 
fear stimuli. Baseline state anxiety predicted US expectancy during fear acquisition, whereas trait 
anxiety predicted US expectancy during fear extinction. 
Limitations: One main limitation is that all experimental procedures were conducted on the same 
day. Considering state anxiety predicted acquisition response whereas trait anxiety predicted 
extinction response, future studies may benefit from a more comprehensive measure of anxiety. 
Conclusions: Findings inform baseline characteristics that predict fear acquisition, extinction, 
and overt avoidance behavior.   
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Introduction 
Anxiety disorders have the highest lifetime prevalence of all psychological disorders; 
they affect 33.7% of adult Americans (Kessler, Petukhova, Sampson, Zaslavsky, & Wittchen, 
2012). These disorders are associated with significant distress or impairment. Susceptibility to 
fear conditioning and deficits in extinction are believed to contribute to the onset and 
maintenance, respectively, of excessive and impairing anxiety (Barlow, 2002). Uncovering 
methods that augment extinction may improve exposure therapy, which is currently used to treat 
anxiety disorders. 
In Pavlovian aversive conditioning, fear is acquired when a neutral conditional stimulus 
(CS) is repeatedly paired with an innately aversive unconditional stimulus (US). As a result of 
this repeated pairing, the CS comes to predict the US, eliciting a conditional fear response. Fear 
is extinguished by presenting the CS numerous times in the absence of the US. In differential 
conditioning, one CS is always paired with the US (i.e., CS+) and another CS is never paired 
with the US (i.e., CS-). The Rescorla-Wagner model of fear learning (1972) theorizes that 
extinction learning relies on the discrepancy between what is expected and what actually 
happens (i.e., error correction). The Pearce-Hall model (1980) emphasizes CS salience (i.e., how 
noticeable the CS is) for extinction learning. Developing techniques that enhance extinction 
learning by enhancing the salience of the CS (thereby possibly enhancing error correction) can 
inform remediation of damaging levels of anxiety. 
Explicit avoidance has been shown to impede extinction by preventing individuals from 
learning that the CS no longer predicts the US (Lovibond, Mitchell, Minard, Brady, & Menzies, 
2009). Yet, anxiety, fear, and fear conditioning are generally thought to involve implicit (i.e., 
reflexive, non effortful) reactions as well as explicit (i.e., conscious) processes (LeDoux, 1996).  
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In order to gain a full understanding of the effects of avoidance on extinction, there is a need to 
evaluate the effect of implicit as well as explicit avoidance processes. Recently, training tools to 
modify implicit approach avoidance tendencies to fear stimuli have been helpful in populations 
of social anxiety disorder and alcohol addiction (Taylor & Amir, 2012; Wiers, Eberly, Rinck, 
Becker, & Lindenmeyer, 2011). To date, there has only been one study assessing whether 
training implicit approach or avoidance to fear stimuli augments extinction learning within a 
fear-conditioning paradigm. Conceivably, implicit approach training to the CS+ would augment 
extinction performance by enhancing the salience of the CS+. A previous study failed to uncover 
an effect of implicit approach avoidance training on subjective and physiological fear 
performance during extinction (Krypotos, Arnaudova, Effting, Kindt, & Beckers, 2015). This 
study sought to re-investigate this by modifying the procedure and methodology. This study also 
expands on the previous one by including a behavioral forced-choice task following extinction to 
measure overt avoidance behavior. Whereas training implicit approach or avoidance may not 
affect extinction performance, it may affect future behavioral avoidance.  
In addition to experimentally manipulating implicit approach avoidance tendencies, we 
were interested in the effects of baseline explicit avoidance on fear acquisition, extinction, and 
overt avoidance behavior. It has been suggested that some individuals have temperamental 
vulnerabilities that make them more likely to acquire fear and less likely to extinguish it (Mineka 
& Zinbarg, 2006; Orr et al., 2000). More specifically, individuals with anxiety seem to have 
heightened fear responses to both the CS+ and CS- suggesting that they have difficulty inhibiting 
fear even to neutral stimuli (Davis, Falls, & Gewirtz, 2000; Duits et al., 2015; Gazendam, 
Kamphuis, & Kindt, 2013; Lissek et al., 2005). However, aside from comparing anxious to non-
anxious populations, there has been little exploration of which baseline characteristics affect fear 
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extinction and avoidance behavior (Lissek et al., 2005). Examining baseline characteristics in 
non-anxious samples may allow us to identify characteristics that make individuals more 
susceptible to fear conditioning or the development of anxiety disorders without confounding 
present symptoms of anxiety. To our knowledge, only one study has looked at non-anxiety 
baseline characteristics in a differential fear-conditioning paradigm (Otto et al., 2007). They 
found that high behavioral avoidance was associated with decreased fear response during fear 
acquisition. Moreover, there is evidence that high avoidance interferes with extinction learning 
(Lovibond, Davis, & O'Flaherty, 2000; Lovibond, Mitchell, Minard, Brady, & Menzies, 2009). 
Together, this would suggest that avoidance interferes with overall learning. This study sought to 
expand upon previous findings by using a measure of explicit avoidance that asks individuals to 
rate their avoidance of “uncomfortable” situations as opposed to a standard list of possible 
phobic situations (e.g., hospital, concert) (Marks & Mathews, 1979). Additionally, we expand on 
the previous study by including a behavioral measure of in vivo avoidance following extinction. 
This study assessed whether training approach or avoidance augments or impedes 
extinction performance and whether it affects future approach avoidance behavior. We expected 
that implicit training to approach rather than avoid the CS+ would attenuate fear response by 
enhancing its salience. Additionally, we investigated baseline explicit avoidance as a predictor of 
fear acquisition, fear extinction, and an in vivo approach avoidance task. We hypothesized that 
individuals with higher behavioral avoidance of uncomfortable situations would exhibit deficits 
in fear acquisition and extinction compared to individuals with lower avoidance. We also 
hypothesized that they would be more likely to avoid fear stimuli on a behavioral test. Secondary 
analyses investigated baseline state and trait anxiety as predictors of fear acquisition, extinction, 
and an in vivo approach avoidance task. We hypothesized that individuals who reported greater 
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state and trait anxiety would exhibit larger fear response during acquisition, deficits in fear 
extinction, and greater likelihood to avoid fear stimuli on a behavioral test. This experiment 
could make an important contribution to the literature on extinction learning in humans.  
Method 
Participants 
Participants (N = 135) were recruited from undergraduate psychology courses at the 
University of California, Los Angeles. Participants were given course credit for their 
participation. Exclusionary criteria include 1) being less than 18 years old, 2) not understanding 
English, 3) having any heart condition, and 4) being told by a physician to stay out of stressful 
environments. The sample was predominantly female (80%), young (M age = 20.22), as well as 
racially and ethnically diverse. Participants described themselves as Asian (33%), White (23%), 
Multiracial (6%), Black/ African American (4%), American Indian/ Alaska Native (1%), Native 
Hawaiian/ Other Pacific Islander (1%), other (25%), and declined to answer (7%). 28% 
identified as Hispanic/ Latino. 
Materials  
Self-report questionnaires. At baseline, participants completed the Acceptance, Safety 
Behaviours, Escape, and Avoidance Scale (AcSEAS; McEvoy, LeBeau, Page, & Craske, in 
prep). The AcSEAS is a 17-item questionnaire with three subscales. The avoidance subscale, 
which is comprised of 5 items, was used. Sample items include “I avoid uncomfortable situations 
at all costs” and “If I am concerned about an upcoming situation, then I just won’t go.” 
Participants were asked to rate how typical or characteristic each item is on a 5-point Likert scale 
from 1 (not typical at all) to 5 (very typical). The avoidance subscale of the AcSEAS has good 
internal consistency (Cronbach’s α = .87, average inter-item correlation = .58) and test-retest 
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reliability (r = .61, p < .001). In our sample, M = 17.36, SD = 4.58, Cronbach’s α = .80. A factor 
analysis revealed an eigenvalue of 2.30 for the first factor and 0.09 for the second factor. Only 
the first factor had an eigenvalue greater than 1, suggesting that the scale items are 
unidimensional; therefore, we retained only one factor. The factor model explained 23.95% of 
the variance in item 1, 55.13% in item 2, 63.54% in item 3, 43.89% in item 4, and 43.41% in 
item 5. 
At baseline, participants also completed The State-Trait Anxiety Inventory (STAI), a 20-
item measure of state and trait anxiety (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). 
Example items include “I feel nervous” and “I feel tense.” Each item is rated on a 4-point Likert 
scale from 1 (not at all) to 4 (to a great extent). The STAI demonstrates good internal 
consistency (State α = .83 - .92, Trait α = 0.90) and the STAI-Trait has good test-retest reliability 
(r = .73 - .86) (Spielberger et al., 1983). In our sample, STAI-State M = 34.64, SD = 8.68 and 
STAI-Trait M = 40.12, SD = 9.72.  
Apparatus and Stimuli. Two geometric shapes of different colors (blue disk, green 
cube) were the CSs, counterbalanced as CS+ or CS- across participants. The CSs appeared one at 
a time in the center of the screen for 8 s. The CS+ was paired with the US during acquisition 
training. The CS- was never paired with the US. The US was a 1 s scream sound presented 
through headphones at 82 db that coterminated with the CS+. Scream sounds have been 
previously and successfully used as USs (Hamm, Vaitl, & Lang, 1989; Joos, Vansteenwegen, & 
Hermans, 2012; Lau et al., 2008; Neumann & Waters, 2006; Sperl, Panitz, Hermann, & Mueller, 
2016). E-prime software was used for stimulus delivery (Psychology Software Tools, Inc., 
Pittsburgh, PA, USA).  
Implicit Approach/ Avoidance Training Task. Our training task was based on 
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procedures used by Krypotos et al. (2015) wherein participants were asked to respond 
differentially to background stimuli of the CS+ or CS-. We made some modifications to the 
Krypotos et al. (2015) procedures. First, instead of approaching or avoiding images on a 
computer screen by using a joystick, participants pressed “c” and “n” keys on a keyboard based 
on the orientation (vertical or horizontal) of the background stimuli. Pressing the “c” and “n” 
keys would cause the CS images to increase or decrease in size giving the illusion that the image 
was getting closer or further away from the participant. Second, instead of responding to the tilt 
of a white background, participants responded to the orientation (horizontal or vertical) of a 
white background. This changed was made with the intent of increasing the salience of the 
background. Third, we increased the training to 3 blocks of 300 trials (250ms ITIs) with 4 
practice trials before each block. Practice trials included images that were different from the CSs. 
Similar to the Krypotos et al. (2015), if participants pressed the wrong key in reaction to a 
background, a red X appeared on the screen and they were required to re-do the trial until they 
pressed the correct key. This was done in order to ensure that images became larger or smaller 
according to group assignment instead of incorrect responses. 
US expectancy. During acquisition and extinction, participants were asked to rate their 
expectancy of the US using a dial from “certain no noise” to “certain noise.” The midpoint of the 
dial was labeled “uncertain.” The following values were added for analyses and graphs -20 
(certain no noise), 0 (uncertain), and 20 (certain noise). Participants were told they could move 
the dial up and down any point on this range. They were told to use the dial continuously 
throughout the experiment even if the CS was not on the screen. The words “scream sound?” 
appeared on the screen 1 s after CS onset and 1 s before US onset as a reminder to continuously 
use the dial. Mean US expectancy ratings were calculated from 1 s to 7 s after CS onset.  
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Skin Conductance Response. Skin conductance response (SCR) was measured using 
Biopac MP150 and Acqknowledge 4.0 programs (Biopac Systems, Inc., Goleta, CA, USA). One 
disposable electrode was placed on the distal phalanx of the middle finger and one on the distal 
phalanx of the index fingers of the non-dominant hand. SCR was calculated as the difference 
between the maximum skin conductance level (measured in microsiemens) during 6 s following 
CS onset and the mean skin conductance level during 2 s prior to CS onset. Data were range 
corrected by dividing each SCR by that individual’s maximum skin conductance level to the US. 
The maximum skin conductance level to the US was calculated as the difference between the 
maximum skin conductance level during 6 s following US onset and the mean skin conductance 
level during 2 s prior to CS onset. The square root of these range-corrected skin conductance 
levels was used to normalize the distribution prior to statistical analyses. SCRs were scored as 
zero if there was no observable peak in skin conductance level within 1 to 6 s following CS 
onset. 
Behavioral Forced Choice Test. Participants were presented with two boxes (12.7 cm x 
10.16 cm). One box included 5.08 cm x 2.54 cm chocolates wrapped in the image of the CS+. 
The other box included the same sized chocolates wrapped in the image of the CS-. The hand in 
which the research assistant held each box was randomized so that the CS+ and CS- were held in 
each hand 50% of the time. Participants were asked to choose one chocolate as a token of 
appreciation for participating in the study. This procedure was modeled after Blechert, Michael, 
Vriends, Margraf, and Wilhelm (2007). 
Procedure 
All experimental procedures were conducted on a single day within a 1.5 hr appointment. 
First, a trained research assistant explained the study procedures, screened for exclusionary 
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criteria, and obtained informed consent. Next, participants completed baseline questionnaires 
using Qualtrics software. Participants were asked to observe images on a computer screen 0.91 m 
in front of them. They were instructed to place headphones around their neck and were told that 
throughout the experiment, they might hear a scream sound through a set of headphones. 
Participants were told to put on their headphones during differential conditioning and extinction. 
They were told to take off their headphones during the implicit approach avoidance training.  
During habituation, participants were shown two images of each CS (CS+, CS-). The 
inter-trial interval (ITI) was randomized across 15, 20, and 25 s with a mean of 20 s throughout 
the entire experiment. The order of the CS presentation was random.  
During differential conditioning, participants received 2 presentations of each CS. The 
final second of the CS+ coincided with a 1 s US (loud noise). The order of the CS+ and CS- was 
random with the exception of no more than two consecutive presentations of each CS.  
 Participants were then randomized to one of four groups. Group 1 (n = 37) underwent 
implicit approach training of the CS+ during which they approached the CS+ 90% of the time, 
avoided the CS+ 10% of the time, and approached/avoided the CS- at a 50-50 rate. This was 
achieved by pairing the CS+ and CS- image with specific backgrounds. The CS+ was presented 
on the background that would zoom big 90% of the time and zoom small 10% of the time, 
whereas the CS- was equally distributed on the zoom big and zoom small backgrounds. Group 2 
(n = 35) underwent implicit avoidance training of the CS+ during which they avoided the CS+ 
90% of the time, approached the CS+ 10% of the time and approached/avoided the CS- at a 50-
50 rate. Group 3 (n = 36) approached and avoided the CS+ and CS- each 50% of the time. Group 
4 (n = 34) completed a filler task (i.e., read a magazine) for 25 minutes, which was the average 
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duration of the implicit approach/ avoidance training derived from pilot testing. Participants were 
told not to put on their headphones during this training phase. 
Next, during fear extinction phase, participants saw eight presentations of each CS 
without the US. The order of CS presentation followed the same randomization as in the 
acquisition phase. Approximately 30 min later, prior to leaving the lab, research assistants asked 
participants to choose one chocolate wrapped in CS+ or CS- image as a token of appreciation for 
participating in the experiment. Unbeknownst to the participant, this task was used as a measure 
of overt avoidance behavior. 
Statistical analyses  
Multi-level modeling with repeated measures design was conducted in Stata 13 using the 
mixed command for analyses on fear response during the acquisition and extinction phases. Two 
level growth curve models were used. Level one was trials nested within subjects. For each trial, 
we had CS type (CS+ or CS-) and position of trial (1-4 for acquisition, 1-8 for extinction). 
Position of trial was modeled as a continuous linear variable. On level 2 we included baseline 
characteristics (explicit avoidance, state anxiety, and trait anxiety) and group assignment 
(approach, avoid, 50-50, filler). Analyses were run separately for each outcome variable (US 
expectancy, SCR) and baseline characteristic. Baseline characteristics were modeled separately 
from each other because of a high correlation between state anxiety and trait anxiety, r = .56, p < 
.001. Modeling them separately also allowed us to limit the total number of terms in a given 
analysis. Models were fitted using maximum likelihood. Random effects of intercept were 
included in all models.  
First, we investigated whether our differential fear-conditioning paradigm worked by 
testing two-way interactions between CS type and trial on US expectancy and SCR. We tested 
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these interactions separately for fear acquisition and extinction phases, giving us a total of 4 
tests. At trial 1 of fear acquisition, we expected no significant difference in US expectancy and 
SCR between the CS+ and CS-. At trials 2-4, we expected higher US expectancy ratings and 
larger SCRs to the CS+ compared to the CS-. At trial 1 of extinction, we expected higher US 
expectancy ratings and larger SCRs to the CS+ compared to the CS-. By trial 8 of extinction, we 
expected no significant difference in US expectancy and SCR between the CS+ and CS-. 
Next, we investigated whether group assignment moderated fear extinction response with 
three-way interactions between CS type, trial, and group assignment on US expectancy and SCR. 
When running these two tests, we used a Stata notation that treats group assignment as a 
categorical predictor with discrete categories. An omnibus test with 3 degrees of freedom was 
used to assess whether the interactions with group assignment were significant. If non-
significant, we investigated a four-way interaction between CS type, trial, group assignment, and 
baseline characteristic on US expectancy and SCR to explore the possibility that group 
assignment affects certain individuals and not others.  
If the four-way interactions and three-way interactions above were non-significant, we 
investigated whether baseline characteristics moderated fear acquisition or extinction response. 
We tested separate three-way interactions between CS type, trial, and each baseline characteristic 
on US expectancy and SCR during acquisition and extinction for a total of 12 tests. For tests on 
extinction response, we included group assignment as a covariate. If these interactions were non-
significant, we examined all two-way interactions. We would have already reported the 
interaction of CS type and trial, so we only reported any significant interactions of baseline 
characteristics and CS type. We did not report the remaining two-way interaction of baseline 
characteristic and trial because we did not want to collapse across CS type in a differential fear-
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conditioning paradigm. Tests of simple effects were used to explain significant interactions. 
Values at 1 SD below and above the mean were used to represent high anxiety/ avoidance or low 
anxiety/ avoidance. For analyses exploring baseline characteristics, Cohen’s f2, a measure of 
effect size, was calculated for statistically significant analyses. We used the method described by 
Selya, Rose, Dierker, Hedeker, and Mermelstein (2012). The reduced models included all 
covariates, main effects, and lower order interactions, whereas the full models included only the 
higher order interaction. Cohen’s f2 of 0.02, 0.15, and 0.35 are considered small, medium, and 
large effect sizes (Cohen, 1988). 
Lastly, we investigated whether group assignment and each baseline characteristic 
predicted chocolate choice on the behavioral forced choice test. Logistic regressions were run in 
Stata 13 using the logit command. We tested a two-way interaction of baseline characteristic and 
group assignment on the probability of choosing the CS+ chocolate. If the two-way interaction 
was non-significant, we investigated main effects of each baseline variable and group assignment 
for a total of 3 tests.   
Results 
Tests of Differential Fear Response 
US Expectancy at Acquisition. A linear mixed model revealed a significant interaction 
of CS type and trial on US expectancy during acquisition, z = 11.03, p < .001 (see Figure 1), 
such that that the slope of the CS+ across trials was positive (z = 5.67, p < .001) and the slope of 
the CS- was negative (z = -4.58, p < .001). Tests of simple effects revealed no significant 
difference in US expectancy to the CS+ and the CS- on trial 1, whereas there were higher US 
expectancy ratings to the CS+ than the CS- at trials 2-4, trial 1: z = 0.28, p = .78; trial 2: z = 9.46, 
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p < .001; trial 3: z = 18.44, p < .001; trial 4: z = 17.96, p < .001. Thus, fear of the CS+ was 
acquired during the acquisition phase. 
 
Figure 1. Predicted US expectancy ratings to the CS+ and CS- across four trials of acquisition. 
There was no significant difference in US expectancy to the CS+ and CS- at trial 1; however, US 
expectancy ratings were higher to the CS+ than CS- at trials 2-4 of acquisition.  
 
 
SCR at Acquisition. A linear mixed model revealed a significant interaction of CS type 
and trial on SCR during acquisition, z = 7.25, p < .001 (see Figure 2), such that the slope of the 
CS+ across trials was positive (z = 5.67, p < .001) and the slope of the CS- was negative (z = -
4.58, p < .001). Tests of simple effects revealed no significant difference in SCR following the 
CS+ and the CS- on trial 1, whereas there were higher SCRs to the CS+ than the CS- at trials 2-
4, trial 1: z = 0.06, p = .95; trial 2: z = 6.01, p < .001; trial 3: z = 11.93, p < .001; trial 4: z = 
11.68, p < .001. Thus, fear of the CS+ was acquired during the acquisition phase. 
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Figure 2. Predicted SCR to CS+ and CS- across four trials of acquisition. There was no 
significant difference in SCR between CS+ and CS- at trial 1; however, there were larger SCRs 
to CS+ than CS- at trials 2-4 of acquisition.  
 
US Expectancy at Extinction. A linear mixed model revealed a significant interaction of 
CS type and trial on US expectancy during extinction, z = -7.83, p < .001 (see Figure 3), such 
that the slopes of the CS+ and CS- across trials were negative, β = -2.30, SE = 0.10, z = -24.20, p 
< .001; β = -1.25, SE = 0.10, z = -13.13, p < .001 respectively. Tests of simple effects revealed 
that there was a significant difference in US expectancy to the CS+ and the CS- at trials 1-7, but 
no significant difference by trial 8, trial 1: z = 13.64, p < .001; trial 2: z = 14.52, p < .001; trial 3: 
z = 15.13, p < .001; trial 4: z = 14.33, p < .001; trial 5: z = 10.99, p < .001; trial 6: z = 6.55, p < 
.001; trial 7: z = 2.98, p = .003; trial 8: z = 0.55, p = .58. Thus fear to the CS+ was extinguished 
during the extinction phase. 
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Figure 3. Predicted US expectancy ratings to CS+ and CS- across eight trials of extinction. US 
expectancy ratings were higher to CS+ than CS- at trials 1-7, whereas there was no significant 
difference at trial 8.  
 
SCR at Extinction. A linear mixed model revealed a significant interaction of CS type 
and trial on SCR during extinction, z = -2.99, p = .003 (see Figure 4), such that the slopes of the 
CS+ and CS- across trials were negative, β = -0.03, SE = 0.003, z = -9.00, p < .001; β = -0.01, SE 
= 0.003, z = -4.78, p < .001 respectively. Tests of simple effects revealed that there was a 
significant difference in SCR to the CS+ and the CS- at trials 1-5, but no significant difference at 
trials 6-8, trial 1: z = 4.51, p < .001; trial 2: z = 4.68, p < .001; trial 3: z = 4.71, p < .001; trial 4: z 
= 4.22, p < .001; trial 5: z = 2.95, p = .003; trial 6: z = 1.43, p = .15; trial 7: z = 0.27, p = .78; trial 
8: z = -0.49, p = .62. Thus, fear to the CS+ was extinguished during the extinction phase. 
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Figure 4. Predicted SCR to CS+ and CS- across eight trials of extinction. SCRs were larger to 
the CS+ than CS- at trials 1-5, whereas there was no significant difference at trials 6-8. 
 
Effect of Group on Extinction 
Linear mixed models revealed non-significant three-way interactions of CS type, trial, 
and group assignment on US expectancy and SCR during extinction ps > .05. The interactions 
continued to be non-significant when baseline characteristics were added to the interaction terms 
ps > .05.  
Effect of Baseline Characteristics on Acquisition 
Linear mixed models revealed non-significant three-way interactions of CS type, trial, 
and each baseline characteristic on US expectancy and SCR during acquisition ps > .05. All two-
way interactions were assessed. A significant interaction between CS type and state anxiety on 
US expectancy emerged, z = -3.72, p = .001, f2 = 0.014 (see Figure 5), such that the difference 
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between the CS+ and the CS- decreased as state anxiety increased. At 1 SD above the mean 
(high state anxiety), the difference between the CS+ and the CS- was 6.34 units (SE = 0.77, z = 
8.22, p < .001), whereas at 1 SD below the mean (low state anxiety), the difference between the 
CS+ and the CS- was 10.39 units (SE = 0.77, z = 13.56, p < .001). Test of simple slopes revealed 
that the slope of the CS+ across state anxiety was not significantly different from 0 (p = .64), but 
the slope of the CS- was positive, β = 0.20, SE = 0.08, z = 2.45, p = .014. Thus, individuals with 
more state anxiety had higher US expectancy ratings to the CS- compared to individuals with 
less state anxiety. There were no significant three-way or two-way interactions for explicit 
avoidance or trait anxiety on US expectancy, ps > .05. There were also no significant three-way 
or two-way interactions for explicit avoidance, state anxiety, or trait anxiety on SCR, ps > .05.   
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Figure 5. Predicted US expectancy ratings to CS+ and CS- for individuals with low, average, 
and high state anxiety. Individuals with high state anxiety had higher US expectancy ratings to 
the CS- than individuals with low state anxiety. 
 
 
Effect of Baseline Characteristics on Extinction 
Linear mixed models assessed three-way interactions of CS type, trial, and each baseline 
characteristic on US expectancy and SCR during extinction. Controlling for group assignment, a 
significant interaction of CS type, trial, and trait anxiety on US expectancy emerged, z = 2.14, p 
= .03, f2 = 0.002 (see Figure 6), such that for low trait anxiety individuals, there was no 
significant difference between US expectancy to CS+ and CS- by trial 7, whereas for high trait 
anxiety individuals there was no significant difference between US expectancy to CS+ and CS- 
by trial 8, ps > .05. Test of simple slopes revealed no significant difference in the slope of the 
CS+ across trials for low and high trait anxiety. There was also no significant difference in the 
slope of the CS- across trials for individuals with low and high trait anxiety. However, linear 
combinations of estimators revealed that the slope of the CS+ was significantly different from 
the slope of the CS- across trials for individuals with low anxiety, coefficient = -1.34, SE = 0.19, 
z = -7.01, p < .001. There was also a significant difference between the slope of the CS+ and the 
slope of the CS- across trials for individuals with high anxiety, coefficient = -.75, SE = 0.19, z = -
3.86, p < .001. The coefficients of the differences of slopes between CS+ and CS- were 
significantly different from each other for low anxiety individuals vs. high anxiety individuals, 
coefficient = .59, SE = 0.27, z = 2.14, p = .03. Therefore, the difference in slopes between CS+ 
and CS- is larger for individuals with low anxiety than high anxiety.  
There were no significant three-way or two-way interactions for explicit avoidance or 
state anxiety on US expectancy, ps > .05. There were also no significant three-way or two-way 
interactions for explicit avoidance, state anxiety, or trait anxiety on SCR, ps > .05.   
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Figure 6. Predicted US expectancy ratings to CS+ and CS- for individuals with low and high 
trait anxiety. Individuals with low trait anxiety had no significant difference in US expectancy 
ratings between CS+ and CS- by trial 7, whereas individuals with high trait anxiety had no 
significant difference between CS+ and CS- by trial 8. 
 
Behavioral Forced Choice Test 
Logistic regressions revealed non-significant interactions of baseline characteristics and 
group assignment on the probability of choosing the CS+ chocolate, ps > .05. We then tested the 
main effect of baseline characteristic and group assignment within the same model. Logistic 
regressions revealed a significant main effect of explicit avoidance on chocolate choice, such that 
as avoidance increased, participants were less likely to choose the CS+ than CS-, z = -2.35, SE = 
0.04, 95% CI [-0.18, -0.02], p = .02 (see Figure 7). 
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 Regardless of group assignment, 80 participants chose the CS- chocolate, whereas 55 
chose the CS+.  One sample test of proportions revealed this rate is significantly different from 
50-50, p = .03. 
  
Figure 7. Greater explicit avoidance predicted less probability of choosing the CS+ chocolate 
compared to less explicit avoidance. 
 
 
A significant main effect of state anxiety also emerged, such that as anxiety increased, 
participants were less likely to choose the CS+, z = -2.04, SE = 0.02, 95% CI [-0.09, -0.002], p = 
.041 (see Figure 8). 
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Figure 8. Higher state anxiety predicted less probability of choosing the CS+ chocolate 
compared to lower state anxiety 
 
Discussion 
First, the goal of the current study was to investigate the effects of manipulating implicit 
approach avoidance tendencies to fear stimuli on extinction performance and overt approach 
behavior. In line with the previous study, which aimed to manipulate implicit approach 
avoidance tendencies, this study did not find significant effects of approach avoidance retraining 
on extinction performance (Krypotos et al., 2015). We also found a non-significant effect of 
training on the behavioral forced choice test. Second, we aimed to expand the literature on 
baseline characteristics that predict acquisition performance, extinction performance, and overt 
avoidance behavior. We found that individuals with high explicit avoidance and high state 
anxiety were less likely to choose fear stimuli on a behavioral forced choice test than individuals 
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with low explicit avoidance and low state anxiety. Additionally, we found that individuals with 
high state anxiety reported higher US expectancy ratings to neutral stimuli during fear 
acquisition compared to individuals with low state anxiety. We also found that individuals with 
high trait anxiety were slower to extinguish their fear than individuals with low trait anxiety. In 
our sample, avoidance and anxiety did not relate to the physiological outcome of SCR. 
Considering the very small effect sizes of significant results it is possible that analyses with SCR 
were not significant simply because of inadequate power. Alternatively, anxious individuals 
physiological response to non-ambiguous fear stimuli may not differ from low anxious 
individuals, but rather, their anxiety impacts their cognitive appraisal of the situation. Previous 
studies have found similar effects of trait anxiety on US expectancy ratings during extinction, but 
not on SCR or fear potentiated startle reflex, another physiological measure of fear (Gazendam et 
al., 2013; Kindt & Soeter, 2014). A third explanation may be that, our sample’s anxiety level 
may not have been high enough to see changes in physiology. In a Post Traumatic Stress 
Disorder sample, delayed fear extinction in SCR to CS+ was found in comparison to non-
anxious individuals (Blechert, et al., 2007). 
Considering that treatment for anxiety disorders includes exposure therapy, 
understanding what baseline characteristics make individuals more likely to approach feared 
stimuli may allow us to better match patients to a particular treatment. Based on our findings, 
avoidance may not change how individuals react to exposures, but it may predict whether they 
would be willing to do the exposures afterward. This would suggest that patients who are highly 
avoidant would benefit from treatments that explicitly explain that patients should be seeking 
ways to approach rather than avoid feared stimuli. Indeed, individuals with high behavioral 
avoidance have been found to benefit from treatments with more explicit and structured focus to 
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avoidance (Mesri et al., 2017). Another possible clinical implication may be that patients may 
benefit from altering their avoidance tendencies prior to starting exposure therapy.  
Our study was limited by the fact that implicit approach or avoidance training did not 
have a significant effect on the behavioral forced choice test, suggesting that such training may 
not be able to change overt behavior after fear conditioning. On the other hand, it is possible that 
non-significant results may point to floor effects with responding, such that there are no added 
benefits of implicit training over and above regular extinction (Vansteenwegen, Crombez, 
Baeyens, & Eelen, 1998). Therefore, implicit training may serve useful only if there is no 
extinction phase. Alternatively, considering this type of training has been shown to change overt 
behavior in previous clinical samples of alcohol addiction, social anxiety disorder, and 
contamination phobia, it is also possible that fear conditioning does not engender extensive 
implicit avoidance as may be the case with a clinical population (Amir, Kuckertz, & Najmi, 
2013; Taylor & Amir, 2012; Wiers et al., 2011). Lastly, effect sizes may have been smaller than 
we expected and thus we had low power with our sample size. Even though we included group 
assignment as a covariate in analyses, the study would benefit from replication without the 
manipulation component. Additionally, we found that state anxiety related to acquisition and 
explicit avoidance and trait anxiety to extinction. A more comprehensive measure of avoidance 
made by standardizing multiple measures would be beneficial moving forward. Another 
limitation is that all experimental procedures were conducted on the same day. Future studies 
would benefit from conducting follow-up procedures following a 24-hour waiting period in order 
to test the effects over time. 
Despite limitations, this is one of few studies that investigated implicit retraining within a 
fear-conditioning paradigm, which may be useful in understanding underlying approach 
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avoidance behaviors. Additionally, this is the first study to look at explicit avoidance in a 
differential fear-conditioning paradigm as a predictor of future avoidance behavior, which may 
help understand the role of avoidance in predicting behavior after exposure therapy. 
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Study 2 
Public Speaking Avoidance as a Treatment Moderator for Social Anxiety Disorder 
 
A version of this work has been previously published. Below is the citation for this work.  
Mesri, B., Niles, A. N., Pittig, A., LeBeau, R. T., Haik, E., & Craske, M. G. (2017). Public 
speaking avoidance as a treatment moderator for social anxiety disorder. Journal of 
Behavior Therapy and Experimental Psychiatry, 55, 66-72. 
doi:http://dx.doi.org/10.1016/j.jbtep.2016.11.010 
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Abstract 
Background and Objectives: Cognitive behavioral therapy (CBT) and acceptance and 
commitment therapy (ACT) have both garnered empirical support for the effective treatment of 
social anxiety disorder. However, not every patient benefits equally from either treatment. 
Identifying moderators of treatment outcome can help to better understand which treatment is 
best suited for a particular patient.  
Methods: Forty-nine individuals who met criteria for social anxiety disorder were assessed as 
part of a randomized controlled trial comparing 12 weeks of CBT and ACT. Pre-treatment 
avoidance of social situations (measured via a public speaking task and clinician rating) was 
investigated as a moderator of post-treatment, 6-month follow-up, and 12-month follow-up 
social anxiety symptoms, stress reactivity, and quality of life.  
Results: Public speaking avoidance was found to be a robust moderator of outcome measures, 
with more avoidant individuals generally benefitting more from CBT than ACT by 12-month 
follow-up. In contrast, clinician-rated social avoidance was not found to be a significant 
moderator of any outcome measure. 
Limitations: Results were found only at 12-month follow-up. More comprehensive measures of 
avoidance would be useful for the field moving forward. 
Conclusions: Findings inform personalized medicine, suggesting that social avoidance measured 
behaviorally via a public speaking task may be a more robust factor in treatment prescription 
compared to clinician-rated social avoidance.   
Keywords: Social anxiety; Moderator; Treatment outcome; Cognitive behavioral therapy; 
Acceptance and commitment therapy  
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Introduction 
Cognitive behavioral therapy (CBT) is a well-established treatment for social anxiety 
disorder (Butler, Chapman, Forman, & Beck, 2006; Hofmann & Smits, 2008). Recently, 
acceptance and commitment therapy (ACT), a third-wave behavioral therapy, has garnered 
support as another effective treatment for social anxiety (Bluett, Homan, Morrison, Levin, & 
Twohig, 2014; Swain, Hancock, Hainsworth, & Bowman, 2013) with comparable treatment 
outcomes to CBT (Craske et al., 2014). Clinically significant response rates of individual patients 
following these interventions are around 50-55%, ranging from 43% to 70% (Craske et al., 2014; 
Leichsenring et al., 2014; Lincoln et al., 2005; Loerinc et al., 2015). Identifying treatment 
moderators may be a key to improving response rates, as they clarify for whom and under which 
circumstances treatments have different effects. Knowledge of such moderators can help 
clinicians better match patients with existing treatments from which they are likely to glean the 
greatest benefit (Kraemer, Wilson, Fairburn, & Agras, 2002). 
Unfortunately, though several predictors of treatment outcome have been identified, little 
research exists on treatment moderators. This is likely due to the fact that the majority of prior 
studies on social anxiety disorder do not compare two active treatments, which is required for 
assessing treatment moderators. To our knowledge, only a few papers have reported moderators 
of psychological treatments for individuals with social anxiety disorder. The findings are detailed 
below. 
In a previously published article on the current sample, individuals with social anxiety 
disorder who were rated as high in experiential avoidance (i.e., self-reported unwillingness to 
accept negative emotions) measured by the Acceptance and Action Questionnaire reported 
greater symptom reduction at 12-month follow-up in CBT than ACT (Craske et al., 2014). The 
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same pattern of moderation was found in a separate study with a mixed anxiety sample 
(Wolitzky-Taylor, Arch, Rosenfield, & Craske, 2012). We speculated that individuals with high 
experiential avoidance benefit more from CBT in the long-term because they are motivated to 
practice skills (e.g., exposures) designed to decrease avoidance of anxious thoughts, feelings, and 
sensations. Compared to CBT, ACT emphasizes acceptance rather than reducing uncomfortable 
internal experiences. Conversely, in the same mixed anxiety sample, individuals with high 
behavioral avoidance of negative physical sensations (i.e., unwillingness to continue a 
hyperventilation task) were more likely to benefit from ACT than CBT (Davies, Niles, Pittig, 
Arch, & Craske, 2015). However, this study did not examine moderators separately by diagnosis 
and thus it is possible that this finding was driven by patients with anxiety primarily related to 
bodily sensations (e.g., those with panic disorder and health anxiety), which is a common but not 
essential or primary component of social anxiety disorder.  
A measure of avoidance that is more specific to social anxiety disorder would be 
avoidance of social situations. Behavioral measures of social avoidance including public 
speaking tasks are ecologically valid and easily implemented in research, but rarely used in 
clinical assessments (Beidel, Turner, Jacob, & Cooley, 1989; Hofmann, Newman, Ehlers, & 
Roth, 1995; Levin et al., 1993; Moscovitch, Suvak, & Hofmann, 2010). Instead, clinicians 
typically make judgments of behavioral avoidance based on patient self-report. However, 
anxious patients’ estimates of their avoidance can be at odds with their actual behavior 
(Rachman & Lopatka, 1986; Taylor & Rachman, 1994). To our knowledge there is no previous 
study evaluating behavioral measures of social avoidance as moderators of treatment outcome 
for social anxiety disorder.  
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Theoretically, experiential and behavioral avoidance are two separate parts of anxiety. 
Whereas experiential avoidance is centered on avoidance of internal experiences such as 
thoughts, feelings, and physical sensation, behavioral avoidance is centered on avoidance of 
external experiences such as social events, public speaking, and meetings. It would seem likely 
that individuals who are avoidant of feared internal experiences would also be avoidant of feared 
external experiences. Moreover, both experiential avoidance and behavioral avoidance are 
indicators of poor emotion regulation (Craske, Street, & Barlow, 1989; Hayes, Wilson, Gifford, 
Follette, & Strosahl, 1996). From a deficit correction model, it is likely that those who show 
deficits in emotion regulation would benefit from a treatment that is targeting said deficit (e.g., 
CBT) compared to a treatment that is not targeting emotion regulation (e.g., ACT).  
Given prior evidence that individuals who report high levels of experiential avoidance 
(indicator of poor emotion regulation) respond more positively to CBT than ACT, we 
hypothesized that those with the most overt social avoidance (another indicator of poor emotion 
regulation), would similarly respond more positively to CBT than ACT. To evaluate the effects 
of in vivo versus clinician-rated social avoidance, we analyzed avoidance via a public speaking 
task and clinician rating prior to treatment. To isolate the effect of social avoidance above social 
fear, we analyzed public speaking avoidance, clinician-rated social avoidance, public speaking 
fear, and clinician-rated social fear as moderators of all outcomes.  
Method 
Participants 
Forty-nine individuals who met diagnostic criteria for principal or co-principal 
generalized social anxiety disorder using the Anxiety Disorders Interview Schedule for DSM-IV 
(ADIS-IV; Brown, Di Nardo, & Barlow, 1994) were included in the current analyses (see Craske 
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et al., 2014 for more details). Fifty-two participants completed treatment but follow-up 
behavioral and self-report data were missing for 3 individuals. A clinician severity rating of 4 or 
higher on the ADIS-IV indicated clinical severity and served as the cutoff for study eligibility. 
Individuals were a subset of a larger sample that included randomization to a waitlist condition 
(Craske et al., 2014). Because moderator analyses examine differential response to two active 
treatments and not differential response to active treatment versus control, we did not include 
participants assigned to the waitlist in these analyses. Demographics for the current subsample 
are in Table 1. There were no significant group differences on any demographic or diagnostic 
variable at baseline. 
Table 1 
 
 
Demographic and Clinical Characteristics of Sample  
 
Characteristic CBT  
(total = 28) 
ACT  
(total = 24) 
Gender (Female) 12 10 
Reported Ethnicity 
     Caucasian/ European American 
     Hispanic/ Latino/ Mexican 
     Asian-American/ Pacific Islander 
     Other 
 
14 
5 
7 
2 
 
14 
4 
4 
2 
Age, in years M=28.18 
SD=6.54 
Range: 18-43 
M=28.78 
SD=6.05 
Range: 19-41 
Education, in years M=15.57 
SD=1.93 
Range: 12-18 
M=15.33 
SD=1.86 
Range: 12-19 
Marital status 
     Married/ Cohabiting 
     Single 
     Other 
 
4 
23 
1 
 
1 
21 
2 
Children (1+) 2 1 
Currently on psychotropic medication 5 7 
Comorbid anxiety disorder 10 11 
Comorbid depressive disorder 7 7 
Social anxiety disorder CSR M=5.61 M=5.58 
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SD=0.74 
Range: 4-7 
SD=1.02 
Range: 4-7 
Refused to do the public speaking task 2 3 
LSAS-Fear 
 
 
M=44.12 
SD=8.21 
Range: 28-62 
M=45.30 
SD=9.96 
Range: 29-62 
LSAS-Avoidance M=38.01 
SD=7.49 
Range: 20-54 
M=40.96 
SD=13.71 
Range: 14-66 
 
Note. CBT = cognitive behavioral therapy; ACT = acceptance and commitment therapy; CSR = 
clinician severity rating; LSAS = Liebowitz Social Anxiety Scale 
 
Exclusion criteria included active suicidal ideation, pregnancy, substance abuse or 
dependence within the last 6 months, bipolar disorder, psychosis, or certain medical diseases. 
Additional exclusion criteria (i.e., left handedness, metal implants, claustrophobia) were included 
due to a neuroimaging component. Individuals were permitted to receive concurrent 
psychotherapy or psychotropic medication if they were stabilized on benozodiazepines and beta 
blockers for a minimum of 1 month; on SSRIs, SNRIs, heterocylics, and MAO inhibitors for a 
minimum of 3 months; and on non-anxiety related psychotherapy for a minimum of 6 months 
prior to study entrance. Individuals were recruited through online and newspaper advertisements 
as well as community flyers and referrals from the greater Los Angeles area. The study took 
place at the Anxiety Disorders Research Center in the University of California, Los Angeles 
(UCLA). 
Design 
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Individuals were assessed prior to treatment (i.e., pre-treatment), within 6 weeks after the 
end of treatment (i.e., post-treatment), 6 months after pre-treatment  (i.e., 6-month follow-up), 
and 12 months after pre-treatment (i.e., 12-month follow-up)1.  
Treatments 
Individuals in CBT and ACT groups received 12 weekly, 1-hr individual therapy sessions 
based on standard manuals2. ACT and CBT were matched on number of exposure sessions but 
differed in framing of the intent of exposure. CBT and ACT were administered by advanced 
clinical psychology students at UCLA (see Craske et al., 2014). Therapists received a two-day 
training session in CBT and ACT by Drs. Craske and Hayes, respectively. They received weekly 
group supervision by Dr. Craske and members of Dr. Craske’s and Hayes’s teams.  
CBT. The 12-session CBT protocol has been effective for social anxiety disorder (Arch 
et al., 2012; Craske et al., 2014). Session 1 included assessment, psychoeducation, and self-
monitoring. Sessions 2-4 covered cognitive restructuring, hypothesis testing, and breathing 
retraining. Session 5-11 included exposures to social stimuli. Session 12 focused on relapse 
prevention. 
ACT. Session 1 included psychoeducation and experiential exercises. Sessions 2-3 
covered creative hopelessness. Sessions 4-5 covered mindfulness, acceptance, and cognitive 
defusion. Sessions 6-11 honed previous skills and introduced value exploration. Exposures were 
used throughout to observe and accept anxiety as well as to engage in valued activities despite 
anxiety. Session 12 created a plan for future use of skills. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  6-month follow-up was approximately 3 months after treatment completion and 12-month 
follow-up was approximately 9 months after treatment completion.	  
2 See authors for a copy of the CBT treatment manual (CBT manual modified from Hope, 
Heimberg, Juster, & Turk, 2000); the ACT manual is published (Eifert & Forsyth, 2005). 	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Moderator Variables 
Public Speaking Avoidance and Fear. At pre-treatment, individuals were asked to give 
a 3-min speech in front of a video camera and two confederates. Speech topics included global 
warming and corporal punishment. These topics were selected to be moderate in terms of 
difficulty and controversy. Individuals were given 5 min to prepare the speech on one or both 
topics. They were instructed to rate their fear level using a 0-100 Subjective Units of Distress 
Scale (SUDS; Wolpe, 1990) with 0 being no fear and 100 being maximum fear at the start of the 
speech, at each 1-min interval, and at the end of the speech. After 3 min, individuals were given 
the opportunity to continue speaking for up to 3 more minutes. Mean SUDS ratings were 
calculated for each individual and analyzed as a measure of fear on the public speaking task. 
Number of minutes spoken was used as a measure of avoidance. Nine individuals who refused 
the public speaking task altogether were given a score of 0 min and SUDS rating of 100. See the 
appendix for the brief protocol used to assess public speaking avoidance. 
Clinician-Rated Social Avoidance and Fear. As part of the pre-treatment ADIS-IV, 
clinicians rated individuals’ avoidance and fear (0 = none, 8 = extreme anxiety or avoidance) of 
13 social situations (e.g., dating, public speaking, speaking with unfamiliar people). Avoidance 
scores for all 13 situations were averaged to create a clinician-rated social avoidance score (α = 
.74). Fear scores for all 13 social situations were also averaged to create a clinician-rated social 
fear score (α = .77).  
Outcome Variables 
Symptom Composite Score. The self-report version of the Liebowitz Social Anxiety 
Scale (LSAS-SR; Fresco et al., 2001) is a 24-item measure of fear and avoidance of social and 
performance situations. Total ratings demonstrate good test-retest reliability (r = .83), internal 
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consistency (α = .95), convergent validity, and sensitivity to change following treatment (Baker, 
Heinrichs, Kim, & Hofmann, 2002). The Social Interaction Anxiety Scale (SIAS; Mattick & 
Clarke, 1998) is a 20-item measure of thoughts, feelings, and behaviors in social situations. The 
SIAS correlates highly with other measures of social phobia and has good internal consistency (α 
= .90) (Osman, Gutierrez, Barrios, Kopper, & Chiros, 1998). The Social Phobia Scale (SPS; 
Mattick & Clarke, 1998) is a 20-item measure of being observed by others during routine 
activities (e.g., eating, writing). The SPS correlates highly with other measures of social phobia 
and has good internal consistency (α = .91) (Osman et al., 1998). Alphas for the LSAS-SR, 
SIAS, and SPS were all at or above .90 in this sample across all time points (Niles, Mesri, 
Burklund, Lieberman, & Craske, 2013). To improve construct validity for the measurement of 
social anxiety severity, a composite was created from the three scales. Z-scores for each measure 
were combined to create a standardized measure with mean 0 and standard deviation 1. The 
LSAS-SR was not administered at 6-month follow-up, which includes only the SPS and SIAS.  
State-Trait Anxiety Inventory. The State-Trait Anxiety Inventory – A State (STAI A-
State; Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983) is a 20-item measure of temporary 
anxiety in response to a stressor. Example items include “I feel nervous” and “I feel tense.” Each 
item is rated on a scale from 1 (not at all) to 4 (to a great extent). The STAI A-State 
demonstrates good internal consistency (α = .83 - .92) (Spielberger et al., 1983). The STAI was 
administered at the start of the laboratory assessment (which included a hyperventilation task, a 
public speaking task, and computer tasks) in order to assess stress reactivity. Because the 
laboratory assessment was not conducted at 6-month follow-up, STAI data were analyzed only at 
pre, post, and 12-month follow-up. 
 	   47  	  
Quality of Life Inventory. The Quality of Life Inventory (QOLI; Frisch, 1994a, 1994b) 
is a measure of satisfaction with regard to 16 broad life domains. Each domain is first rated for 
importance on a scale from 0 (not important) to 2 (extremely important). Then, individuals rate 
their life satisfaction with that domain from -3 (very dissatisfied) to +3 (very satisfied). The 
QOLI demonstrates good test-retest reliability (r = .80 - .91), internal consistency (α = .77 - .89), 
and sensitivity to treatment change (Frisch et al., 2005). 
Statistical analyses 
 A multi-level model with repeated measures design was used. Pre-treatment scores were 
modeled as a covariate rather than a repeated measure to minimize the variance in the outcome 
measures (Tabachnick & Fidell, 2006). This model has been previously used in examining 
moderators of treatment outcome (Craske et al., 2014; Niles et al., 2013; Wolitzky-Taylor et al., 
2012).  
Analyses were run in Stata 13 using the xtmixed command. A two level growth curve 
model was used. On level 1, we included Time (post-treatment, 6-month follow-up, 12-month 
follow-up) as a categorical predictor. On level 2, we included baseline levels of the outcome 
measures (as a covariate), Group (CBT or ACT), status (0 = completed 12-month measures, 1 = 
not completed 12-month measures), and the interactions with the moderators. To test the 
specificity of public speaking avoidance as a moderator above fear, we included fear during the 
public speaking task as a covariate. When testing public speaking fear, we included public 
speaking avoidance as a covariate. Pairwise correlations between public speaking avoidance and 
public speaking fear revealed only a moderate correlation, r = -.39, p < .001. However, pairwise 
correlations between clinician-rated social avoidance and clinician-rated social fear revealed a 
strong correlation, r = .81, p < .001. Hence, we did not include clinician-rated social fear in the 
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model when analyzing clinician-rated social avoidance and vice versa. Cohen’s f2, a measure of 
effect size, was calculated for all statistically significant models using the method described by 
Selya, Rose, Dierker, Hedeker, and Mermelstein (2012). Reduced models included all covariates, 
main effects, and two-way interactions, whereas full models added the three-way interactions. 
Cohen’s f2 of 0.02, 0.15, and 0.35 are considered small, medium, and large effect sizes (Cohen, 
1988). Models were fitted using full maximum likelihood. Random effects of intercept were 
included in all models.  
Because moderators may interact with Group (CBT or ACT) or Time, we tested three-
way interactions between moderator, Group, and Time. If the three-way interaction was non-
significant, we included Time as a covariate and tested the two-way interaction between 
moderator and Group. Tests of simple effects were used to explain moderation effects. More 
specifically, values 1 SD below and above the mean were used to represent high avoidant/ fear or 
low avoidant/ fear individuals. Values at 1 SD were used in order to capture representative 
avoidance or fear behavior in a social anxiety group, which is typical in previous moderation 
studies (Niles et al., 2013). 
Results 
As reported in Craske et al. (2014), CBT and ACT were each more effective than a 
waitlist comparison control for symptoms of social anxiety, with no significant differences 
between them.  
Moderator of Symptom Composite 
Public speaking avoidance significantly interacted with Group and Time to moderate 
symptom composite, z  = -2.49, p = .045, f2 = 0.06 (see Figure 1). Tests of simple effects revealed 
that at 12-month follow-up, more avoidant individuals (operationally defined as 1 SD above the 
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mean) reported .87 SD fewer symptoms following CBT than ACT, 95% CI [0.05, 1.70], z = 
2.07, p = .038. No group differences were found for low avoidant individuals (1 SD below the 
mean), p > .05. Public speaking avoidance did not moderate post-treatment or 6-month follow-
up, ps > .05. Neither fear on the public speaking task nor clinician-rated social avoidance or 
social fear were significant moderators of symptom composite at any time point, ps > .05. 
	  
Figure 1. Public speaking avoidance significantly interacted with Group and Time to moderate 
symptom composite. By 12-month follow-up more avoidant individuals reported fewer 
symptoms following CBT than ACT. CBT = cognitive behavioral therapy; ACT = acceptance 
and commitment therapy 
Moderator of Stress Reactivity  
Public speaking avoidance significantly interacted with Group and Time to moderate 
stress reactivity (measured by STAI A-State prior to a stressful laboratory assessment), z = -3.87, 
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p < .001, f2 = 0.27 (see Figure 2). Tests of simple effects revealed that at 12-month follow-up, 
more avoidant individuals reported 15.77 fewer points in stress reactivity following CBT than 
ACT, 95% CI [8.38, 23.17], z = 4.18, p < .001. No group differences were found for low 
avoidant individuals, p > .05. Public speaking avoidance did not moderate stress reactivity at 
post-treatment or 6-month follow-up, ps > .05. Neither fear on the public speaking task nor 
clinician-rated social avoidance or social fear were significant moderators of stress reactivity at 
any time point, ps > .05. 
 
Figure 2. Public speaking avoidance significantly interacted with Group and Time to moderate 
stress reactivity. By 12-month follow-up, more avoidant individuals reported less stress 
reactivity following CBT than ACT. CBT = cognitive behavioral therapy; ACT = acceptance and 
commitment therapy 
Moderator of Quality of Life 
Clinician-rated social fear significantly interacted with Group and Time to moderate 
quality of life, z = -3.21, p = .006, f2 = 0.16 (see Figure 3). Tests of simple effects revealed that at 
6-month follow-up, less fearful individuals reported 1.32 fewer points in quality of life following 
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CBT than ACT, 95% CI [-2.33, -0.31], z = -2.56, p = .010 and more fearful individuals reported 
1.26 more points in quality of life following CBT than ACT, 95% CI [0.003, 2.52], z = 1.96, p = 
.049. There were no significant differences between high and low clinician-rated fearful 
individuals in CBT and ACT at post-treatment and 12-month follow-up, ps > .05. Therefore, this 
finding is no longer discussed in this paper. Public speaking fear, public speaking avoidance, and 
clinician-rated social avoidance were not significant moderators of quality of life at any time 
point, ps > .05. 
 
Figure 3. Clinician-rated social fear significantly interacted with Group and Time to moderate 
quality of life. At 6-month follow-up, less fearful individuals reported significantly lower quality 
of life in CBT than ACT, whereas more fearful individuals had a non-significant trend for higher 
quality of life in CBT than ACT. CBT = cognitive behavioral therapy; ACT = acceptance and 
commitment therapy 
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Discussion 
The current study tested social avoidance as a moderator of treatment outcome for social 
anxiety disorder. Understanding moderators of treatment outcome allow us to better match 
patients to a particular treatment, which has important implications for improving treatment 
outcome. Our findings suggest that individuals who are more avoidant during a public speaking 
task benefit more, in terms of long-term symptoms and stress reactivity, from CBT than ACT.  
Conversely, fear during the public speaking task did not moderate the treatment effects, 
suggesting that the results were specific to public speaking avoidance versus fear. Moreover, 
clinician-rated social avoidance did not moderate treatment effects, which could imply that the 
results were specific to avoidance of public speaking in particular rather than social avoidance in 
general. Alternatively, these results may suggest that clinicians may not be particularly accurate 
judges of a patient’s degree of social avoidance in their daily life. Such judgments are likely to 
be heavily reliant on a patient’s self-report, particularly at an initial assessment when the 
clinician has limited information about the patient, and self-report of avoidance behavior may not 
be an exact indicator of actual avoidance behavior in laboratory paradigms (Gamez, Kotov, & 
Watson, 2010; McNeil, Ries, & Turk, 1995). Another explanation for the non-significant effects 
of fear during the public speaking task and clinician-rated social avoidance may be low power. 
Power to detect an effect size of the same magnitude as those that we detected for the public 
speaking avoidance ranged from .74 - .86 for f2 = 0.27 and .17 - .22 for f2 = 0.063. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  There is a lack of statistical software to conduct power analyses for multi-level repeated 
measures; as an approximation, we used G*Power for linear models to calculate post hoc power 
analyses at alpha = .05 (Faul, Erdfelder, Lang, & Buchner, 2007). The number of predictors 
ranged from 10 to 13, so we calculated two values of power (more and less conservative). 
Because we have repeated measures, we calculated the sample size correcting for the design 
effect using the equation: design effect = 1 + (n-1)ρI, where n = the number of time points (3) 
and ρI =  intraclass correlation (Snijders & Bosker, 2012). We used the smallest and largest 
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We found that more avoidance on the public speaking task predicts better long-term 
outcome in CBT than ACT. One possible explanation is that CBT targets avoidance in a 
structured way through creation of an exposure hierarchy followed by in-session and homework 
exposure assignments. Avoidant individuals may benefit from this structure. A similar finding 
has been reported in a panic disorder sample that was randomly assigned to exposure therapy 
with an active therapist who guided patients through exposures or a less active therapist who was 
not present during assigned exposures (Hamm et al., 2016). Overall, panic disorder patients 
benefitted from exposure therapy; however, patients with greater baseline avoidance of a panic 
booth benefitted even more from therapist-directed exposures than self-directed exposures 
compared to patients who were less avoidant of the panic booth. This finding may highlight the 
added benefit of structure during exposures (which may be more present in CBT than ACT) for 
patients with high public speaking avoidance. Although ACT includes exposure, these exposures 
are less structured and their focus is not on fear reduction. Rather, in ACT, individuals conduct 
exposures in order to be present, open, mindful, and accepting of their anxious feelings with the 
eventual goal of taking committed action toward their values. Thus, in contrast to CBT in which 
exposures are a critical strategy for alleviating symptoms, the connection between exposures and 
treatment goals is more removed in ACT and possibly simply one of many approaches toward 
valued living. Indeed, there was greater adherence to behavioral exposures in CBT than ACT in 
the present sample (Craske et al., 2014).  
Moderation was found only at the 12-month follow-up, which replicated our prior studies 
in the same and different samples (Craske et al., 2014; Niles et al., 2013; Wolitzky-Taylor et al., 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
intraclass correlations, to calculate a more conservative sample size of 71 and less conservative 
sample size of 78. Cohen’s f2 of 0.02, 0.15, and 0.35 are considered small, medium, and large 
effect sizes (Cohen, 1988).	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2012). In prior studies, we proposed that experiential avoidance motivated continued exposure 
practice over the months following treatment, in turn leading to improved long-term outcomes 
(Wolitzky-Taylor et al., 2012). Perhaps those who were most avoidant of public speaking 
similarly perceived the benefits of continued exposure practice following the end of treatment 
resulting in better long-term outcome in CBT than ACT. It is also important to note that CBT 
was supervised directly by Dr. Craske and her team, whereas ACT was only supervised by Dr. 
Hayes’s team and not himself. It is possible that if Dr. Hayes had supervised the therapists, 
outcomes from ACT may have differed. Moreover, more comprehensive measures of avoidance 
would be useful for the field moving forward.  
Despite limitations, this is one of few studies that investigated moderators of ACT and 
CBT for social anxiety disorder. Asking patients to give a speech and identifying how long they 
are willing to speak may be a simple way of assessing behavioral avoidance. It may provide 
useful long-term prognostic information not gleaned by traditional methods such as rating levels 
of social avoidance based largely on patient self-report. Furthermore, should these results be 
replicated, they suggest that those who are more behaviorally avoidant may benefit more from 
CBT than ACT. 
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Study 3 
 
Avoidance and Fear Moderate CBT for Panic Disorder and  
Agoraphobia: A Randomized Control Trial 
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Abstract 
Cognitive behavioral therapy (CBT), a well-validated treatment for panic disorder, comprises of 
interoceptive exposures (i.e., exposures to panic-like physiological sensations) and/or in vivo 
exposures (i.e., exposures to real-world situations). Testing predictors and moderators of CBT 
outcomes can improve treatment efficacy. Sixty-six individuals diagnosed with panic disorder 
with or without agoraphobia were randomized to panic control therapy (PCT) (n = 32) or PCT 
and in vivo exposures (PCT + IV) (n = 34) at the Anxiety and Depression Research Center in the 
University of California, Los Angeles. Baseline behavioral measures of interoceptive and in vivo 
avoidance were tested as predictors and moderators of outcomes. Interoceptive fear, in vivo fear, 
demographic factors, and clinical characteristics were also tested. Diagnosticians who measured 
outcomes were blind to participants’ treatment assignment. Multi-level models with repeated 
measures design revealed that individuals who displayed more in vivo avoidance, in vivo fear, 
and interoceptive fear fared better following PCT than PCT + IV compared to individuals who 
displayed less in vivo avoidance, in vivo fear, and interoceptive fear, z = 2.23, SE = 0.11, p = 
.03, 95% CI [0.03, 0.44], f2 = 0.10; z = -2.81, SE = 0.14, p = .01, 95% CI [-0.65, -0.11], f2 = 0.14; 
z = -2.21, SE = 0.25, p = .03, 95% CI [-1.03, -0.06], f2 = 0.07, respectively. Results suggest that 
these individuals benefit from concentrated doses of exposures to their primary interoceptive 
concerns instead of additional in vivo exposures. Findings inform clinical decision-making and 
personalized medicine. Limitations include low power for detecting small effect sizes.  
Keywords: panic disorder, agoraphobia, predictor, moderator, cognitive behavioral 
therapy 
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Introduction 
 
Panic disorder, which is characterized by fear that panic attacks will lead to catastrophic 
consequences (e.g., heart attack), is highly comorbid with agoraphobia (APA, 2013; Kessler et 
al., 2006). Agoraphobia is characterized by fear and avoidance of places (e.g., concerts) that are 
hard to escape in the event of panic-like or other incapacitating symptoms (APA, 2013). 
Exposure-based therapies such as cognitive behavioral therapy (CBT) are considered gold 
standard treatments for both panic disorder and agoraphobia (Hofmann, Asnaani, Vonk, Sawyer, 
& Fang, 2012; Mitte, 2005; Moscovitch, Antony, & Swinson, 2009). Despite a large amount of 
support for CBT, a recent systematic review found that 53% of individuals who were diagnosed 
with both panic disorder and agoraphobia did not achieve clinically significant improvement 
following CBT (Loerinc et al., 2015). A review of four studies on panic disorder without 
agoraphobia found that 28% of participants did not achieve clinical improvement (Siev & 
Chambless, 2007). One way to increase the efficacy of CBT is to test predictors and moderators 
of treatment outcomes (Marks, 2002; Shoham & Insel, 2011). Predictors elucidate which 
individuals have the lowest response rates and moderators clarify whether certain individuals 
benefit more from one treatment or another (Insel, 2009).  
The most commonly tested predictors of treatment outcomes are demographic factors, yet 
it appears that these have little predictive power (Kraemer, Wilson, Fairburn, & Agras, 2002; 
Porter & Chambless, 2015; Schneider, Arch, & Wolitzky-Taylor, 2015). No conclusions have 
been made about whether demographic factors moderate responses to treatment because of the 
dearth of such studies. This may be because moderation analyses require studies that compare 
two or more active treatments as opposed to studies that compare a single active treatment and a 
non-active control (Kraemer et al., 2002).  
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Nevertheless, previous research has shown that clinical factors (e.g., duration of episode, 
age of onset) predict outcomes. From their review of five studies, Porter and Chambless (2015) 
concluded that individuals with older age of onset and shorter duration of panic disorder fared 
better in CBT compared to individuals with younger age of onset and longer duration of panic 
disorder. To our knowledge, only two studies investigated clinical factors as moderators of CBT 
outcomes. Dow et al. (2007) found that individuals whose last panic episodes were longer fared 
better after 12 weeks of CBT than 6 weeks of CBT compared to individuals whose episodes were 
shorter. Unlike the aforementioned study, age of onset was not a significant moderator. On the 
other hand, El Alaoui et al. (2013) found that individuals with later onsets of panic disorder fared 
better after internet-CBT than group-CBT compared to individuals with earlier onsets. 
Considering the limited research on clinical characteristics as moderators of CBT outcomes, no 
definitive conclusions can be made in terms of their role in treatment prescription.  
In addition to demographic and clinical factors, theory-driven predictors and moderators 
can be investigated (Kraemer et al., 2002). A central theoretical factor in the diagnosis, 
maintenance, and treatment of panic disorder and agoraphobia is avoidance (Craske & Barlow, 
1988). Interoceptive avoidance refers to avoidance of panic-like physiological sensations (e.g., 
racing heart, shortness of breath), whereas in vivo (or agoraphobic) avoidance refers to 
avoidance of situations (e.g., crowds) or places (e.g., malls). In a systematic review, Porter and 
Chambless (2015) reported that baseline in vivo avoidance was the most consistent predictor of 
response to CBT for panic disorder with or without agoraphobia. Specifically, individuals with 
greater in vivo avoidance did worse following CBT compared to those with less avoidance. 
Consequently, it is important to test whether these individuals respond better to different type of 
treatment. It is also important to elucidate the role of interoceptive rather than in vivo avoidance.  
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To our knowledge, only two studies on panic disorder or agoraphobia have tested 
whether baseline avoidance moderates treatment outcomes between two different types of CBT. 
Both of these studies are limited to measures of in vivo avoidance. Dow et al. (2007) found that 
baseline self-reported in vivo avoidance did not moderate treatment efficacy between 12-week 
and 6-week CBT. In contrast, Hamm et al. (2016) found that avoidance, measured using a 
behavioral avoidance test rather than self-report, moderated response to exposure therapy. As 
part of a multi-site randomized control trial (RCT), 301 individuals with panic disorder and 
agoraphobia were randomized to (a) exposure therapy accompanied by a therapist or (b) 
exposure therapy that was not accompanied by a therapist. At baseline, participants were asked 
to enter a panic booth (small, dark, enclosed chamber) for 10 min. Of the 226 individuals who 
had complete data, individuals who were avoidant of the panic booth did better following 
therapist accompanied exposures than non-accompanied ones. It was theorized that avoidant 
individuals benefit from a treatment that more actively and systematically targets that avoidance. 
This finding suggests that in vivo avoidance can be used to better match individuals to treatment.  
The goal of the present study was to investigate both in vivo and interoceptive avoidance 
as predictors and moderators of treatment outcomes. In the primary outcome paper, Craske, 
DeCola, Sachs, and Pontillo (2003) found that two different types of CBT were equally 
efficacious for panic disorder and agoraphobia. From a deficit correction perspective and in line 
with previous findings (e.g., Hamm et al., 2016), we hypothesized that individuals who are more 
avoidant of interoceptive cues would benefit more from CBT that emphasizes interoceptive 
exposures, compared to individuals who are less avoidant of interoceptive cues. Additionally, we 
hypothesized that individuals who are more avoidant of in vivo situations would benefit more 
from CBT that emphasizes in vivo exposures, compared to individuals who are less avoidant of 
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in vivo situations. We also tested whether fear (controlling for avoidance), clinical 
characteristics, and demographic characteristics predicted or moderated treatment outcomes.  
Method 
Design 
Individuals were assessed prior to treatment (i.e., pre-treatment), after 8 weeks of starting 
treatment (i.e., mid-treatment), after 16 weeks of starting treatment (i.e., post-treatment), and 6 
months after post-treatment (i.e., 6-month follow-up).  
Participants 
Seventy-seven individuals with a principal diagnosis of panic disorder with or without 
agoraphobia were assessed as part of an RCT at the Anxiety and Depression Research Center in 
the University of California, Los Angeles (see Craske et al., 2003 for more details). Participants 
were recruited via radio advertisements and community referrals. Informed consent was obtained 
upon study enrollment. Independent diagnosticians used a semi-structured interview, the Anxiety 
Disorders Interview Schedule (ADIS-IV; Brown, Di Nardo, & Barlow, 1994) for the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV; APA, 1994). 
Half of the participants were randomized with 1:1 allocation ratio to 16 weeks of panic 
control therapy (PCT), whereas the other half was randomized to eight weeks of PCT followed 
by eight weeks of therapy focused on in vivo exposures (PCT + IV). Of the 77 individuals who 
enrolled in the study, 9 dropped out prior to starting treatment and 2 were removed from the 
study (see Craske et al., 2003 for more details). Table 1 includes baseline demographic 
characteristics of the remaining 66 individuals.  
Table 1 
 
Subsample Baseline Demographic and Clinical Characteristics by Treatment Group 
 	   61  	  
Treatment group PCT 
(n = 32) 
PCT + IV 
(n = 34) 
Gender  
     Female 
     Male 
 
17 
15 
 
22 
12 
Ethnicity 
     Caucasian/European American  
     Hispanic/Latino/Mexican  
     African American/Black 
     Asian American/Pacific Islander 
     American Indian/Alaskan 
     Other 
 
24 
1 
2 
2 
0 
1 
 
22 
6 
2 
0 
0 
1 
Age, in years M = 38.10 
SD = 9.36 
Range: 18 – 53 
M = 32.33 
SD = 9.86 
Range: 18 – 54 
Education, in years M = 15.10  
SD = 2.45 
Range: 12 – 18 
M = 15.27 
SD = 1.94 
Range: 12 – 18 
Psychotropic medication 
     Current use 
     History of use 
     Never used 
 
14 
8 
10 
 
12 
11 
11 
Duration in years since first panic 
attack  
M = 10.10 
SD = 10.08 
Range: 0.58 – 36 
M = 7.02 
SD = 9.11 
Range: 0.58 – 36 
Age of onset M = 28.47 
SD = 11.68 
Range: 8 – 47.75 
M = 25.36 
SD = 9.68 
Range: 13 – 47.75 
Panic disorder CSR M = 5.94 
SD = 0.67 
Range: 5 – 7 
M = 5.91 
SD = 0.79 
Range: 5 – 7 
Agoraphobia 
     None to mild 
     Moderate to severe  
 
5 
26 
 
6 
28 
 
Note. Subsample sizes do not always add up to the total number in each group because of 
missing data for certain variables. CSR = clinical severity rating. Data were Winsorized at the 1st 
and 99th percentiles.  
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Exclusion criteria included psychosis, current substance use disorder, bipolar disorder, 
organic brain damage, pregnancy, severe medical conditions, and asthma. Individuals were 
permitted to use concurrent psychotropic medication if they had stabilized on their dosage and 
agreed to maintain that dosage through post-treatment. They were permitted to receive 
concurrent psychotherapy if the therapy (a) did not target panic disorder or agoraphobia, (b) 
began more than 6 months prior to study enrollment, and (c) was maintained through post-
treatment. Participants were excluded if they received CBT for panic disorder or agoraphobia 
within 2 years prior to enrolling in the study.   
Treatments 
All participants received 16 weekly (90 min) group CBT sessions consisting of 3-5 
patients and 2 therapists (see Craske et al., 2003 for more details). Therapists were graduate 
students and post-doctoral fellows trained by Dr. Craske.  
For all participants, the first eight sessions comprised of PCT, a well-supported 
manualized treatment for panic disorder and agoraphobia (Barlow, Craske, Cerny, & Klosko, 
1989; Craske & Barlow, 2007). PCT includes psychoeducation, breathing retraining, cognitive 
restructuring, and interoceptive exposures. Interoceptive exposures include engaging in activities 
that induce panic-like physiological symptoms (e.g., hyperventilating). Participants were also 
encouraged to go to places or engage in activities that activate physiological concerns (e.g., 
exercising).  
For sessions 9-16, the PCT group repeated the first eight sessions, except that at session 
9, they were encouraged to conduct in vivo exposures if they thought that such exposures would 
be beneficial. In vivo exposures include going to places that do not inherently induce panic 
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sensations, but where escaping or receiving help is difficult in the event of panic-like or other 
incapacitating symptoms (e.g., crowded concert). They were not given specific instructions or 
feedback on implementing in vivo exposures. In contrast, the PCT + IV group spent sessions 9-
16 focused on in vivo exposures. Participants made a new fear hierarchy and were instructed on 
applying panic control techniques (i.e., breathing retraining, cognitive restructuring, 
interoceptive exposures) to in vivo exposures. As reported in Craske et al. (2003), therapist 
adherence to protocol was 5.52 for PCT and 5.49 for PCT + IV on a scale from 1 (no adherence) 
to 7 (extensive adherence). 
Predictors and Moderators  
Interoceptive avoidance and fear. At baseline, participants engaged in three 
counterbalanced interoceptive tasks: hyperventilating (i.e., deep and rapid breathing) for up to 60 
s, spinning (i.e., standing and turning once every 3 s) for up to 90 s, and tube breathing (i.e., 
restricted breathing through a small tube) for up to 120 s (Lee et al., 2006; Schmidt & 
Trakowski, 2004). Durations were all positively correlated and were summed after being divided 
by the maximum per task: hyperventilating and spinning, rs(66) = .65, p < .001; hyperventilating 
and tube breathing, rs(66) = .24, p = .05; tube breathing and spinning, rs(66) = .40, p = .001. One 
participant who refused to do the tube breathing received a time of 0 s.  
To distinguish avoidance from fear, participants rated their anticipatory fear before each 
task and their maximum fear during each task on scales from 0 (not at all) to 8 (extreme). We 
averaged the anticipatory and maximum ratings because they were moderately or strongly 
correlated: hyperventilating, rs(66) = .45; spinning rs(66) = .66; tube breathing rs(66) = .51, ps < 
.001. Then, ratings were averaged across the tasks because they were moderately to strongly 
correlated: hyperventilating and spinning, rs(66) = .72; hyperventilating and tube breathing, 
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rs(66) = .59; tube breathing and spinning, rs(66) = .60, ps < .001. Table 2 includes means, 
standard deviations, and ranges for interoceptive avoidance and fear by treatment group. 
In vivo avoidance and fear. In vivo avoidance and fear were measured via panic booth 
behavioral task and diagnostician rating. We did not combine these measures because of weak 
correlations: panic booth and diagnostician-rated avoidance, rs(60) = .28, p = .03; panic booth 
and diagnostician-rated fear, rs(62) = .39, p < .002. Table 2 includes means, standard deviations, 
and ranges for in vivo avoidance and fear by treatment group. 
Panic booth avoidance and fear. At baseline, participants entered a panic booth (i.e., 2 ft 
x 3 ft x 7 ft dark, enclosed space with a door that could not be opened from the inside) for up to 
10 min, with longer durations indicative of less avoidance (e.g., Hamm et al., 2016). Six 
individuals who refused received a time of 0 min. To distinguish avoidance from fear, 
participants rated their anticipatory fear before the task as well as their maximum fear during the 
task on a scale from 0 (not at all) to 8 (extreme). We averaged anticipatory and maximum fear 
because they were strongly correlated, rs(63) = .76, p < .001.  
Diagnostician-rated in vivo avoidance and fear. As part of the baseline ADIS-IV, 
diagnosticians rated participants’ avoidance and fear of 22 in vivo situations on a scale from 0 
(no avoidance or escape/ no apprehension) to 8 (very severe: never enters even with safe person/ 
very severe apprehension). Separate sums for avoidance and fear were used. We cannot report 
the internal consistency of these ratings because we are missing the raw data.  
Table 2  
 
 
Subsample Baseline Avoidance and Fear Ratings by Treatment Group 
 
Treatment group PCT 
(n = 32) 
PCT + IV 
 (n = 34) 
Sum of interoceptive duration (0-3) M = 2.61 M = 2.67 
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SD = 0.48 
Range: 1.10 – 3 
SD = 0.44 
Range: 1.38 – 3 
Interoceptive average fear (0-8) M = 3.35 
SD = 1.81 
Range: 0.5 – 7.17 
M = 3.90 
SD = 1.89 
Range: 0.33 – 7.17 
Panic booth duration in min (0-10) M = 8.25 
SD = 3.49 
Range: 0 – 10 
M = 8.51 
SD = 3.51 
Range: 0 – 10 
Panic booth average fear (0-8) M = 3.66 
SD = 2.76 
Range: 0 – 8 
M = 4.48 
SD = 2.59 
Range: 0 – 8 
Sum of diagnostician-rated in vivo 
avoidance (0-176) 
M = 42.95 
SD = 26.20 
Range: 4 – 97 
M = 45.81 
SD = 38.40 
Range: 4 – 127 
Sum of diagnostician-rated in vivo 
fear (0-176) 
M = 56.05 
SD = 25.75 
Range: 9 – 112 
M = 55.92 
SD = 35.42 
Range: 9 – 127 
 
Note. Data were Winsorized at the 1st and 99th percentiles. 
Demographic and clinical characteristics. At baseline, participants completed 
questionnaires with demographic characteristics. Gender (1 = male, 2 = female) and ethnicity (1 
= Caucasian/European American, 2 = Hispanic/Latino/Mexican, 3 = African American/Black, 4 
= Asian American/Pacific Islander, 5 = American Indian/Alaskan, 6 = other) were coded as 
categorical variables. For analyses, we used a categorical measure of ethnicity (1 = Caucasian, 2 
= not Caucasian) because 75.41% of the sample was Caucasian. Age in years and education (i.e., 
highest grade completed) were coded as continuous variables. Diagnosticians collected the 
following characteristics during the ADIS-IV: use of psychotropic medication as a categorical 
variable (1 = current use, 2 = history of use, 3 = never used psychotropic medication); duration in 
years since first panic attack as a continuous variable; and age of onset (i.e., baseline age minus 
duration in years since first panic attack) as a continuous variable. See Table 1 for specific values 
of demographic and clinical characteristics.  
Outcome Variables 
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 Independent diagnosticians who were blind to treatment conditions administered the 
ADIS-IV at baseline, mid-treatment, post-treatment, and 6-month follow-up. Outcome measures 
for the current set of analyses come from the ADIS-IV.4  
 Panic disorder. Diagnosticians rated three measures of panic disorder on the ADIS-IV: 
(a) frequency of panic attacks per month, (b) participant’s apprehension of having a panic attack 
on a scale from 0 (not at all) to 8 (extreme), and (c) clinical severity rating (CSR) of distress and 
disablement on a scale from 0 (not at all) to 8 (extreme) for panic disorder. CSRs of 4 or higher 
represent a clinically significant condition. The ADIS-IV has good to excellent diagnostic 
reliability for panic disorder with or without agoraphobia (κ = .72 - .79) and excellent inter-rater 
reliability for panic disorder CSR (κ = .83) (Brown, Di Nardo, Lehman, & Campbell, 2001).  
 Agoraphobia. In the agoraphobia section of the ADIS-IV, diagnosticians rated the 
severity of distress and disablement for agoraphobia on scales from 0 (not at all) to 8 (extreme). 
The average of the two ratings was used because they were strongly to very strongly correlated: 
pre-treatment, rs(58) = .72; mid-treatment, rs(47) = .98; post-treatment, rs(40) = 1.00; 6-month 
follow-up, rs(27) = 1.00, ps < .001. 
Statistical Analyses 
Outliers on all continuous variables (i.e., values less than 1% or greater than 99%) were 
replaced with the nearest non-outlier value based on the Winsor method (Tukey, 1962). Less 
than two percent of the data were Winsorized. 
Multi-level models with repeated measures design were run in Stata 13 using the mixed 
command. On level 1, we included time (post-treatment, 6-month follow-up) as a categorical 
variable. On level 2, we included group (PCT, PCT + IV) and predictors/ moderators (all main 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 Self-report outcome measures were not analyzed because more than 50% of participants did not 
return questionnaires. These measures were also excluded from the primary outcome paper. 
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effects and interactions). Pre-treatment and mid-treatment scores were modeled as covariates 
rather than repeated measures to minimize the variance in the outcome measures (Tabachnick & 
Fidell, 2006). This model has been previously used in examining moderators of treatment 
outcomes (e.g., Craske et al., 2014; Niles, Mesri, Burklund, Lieberman, & Craske, 2013).  
 To test the specificity of avoidance as a predictor or moderator over and above fear, we 
included fear on that task as a covariate (level 2). To test the specificity of fear over and above 
avoidance, we included avoidance on that task as a covariate (level 2). We did this only if there 
was enough non-shared variance between the two variables, which was the case for interoceptive 
and panic booth avoidance and fear, but not for diagnostician-rated avoidance and fear.5 
Shapiro-Wilk tests revealed normally distributed histograms of residuals for all models 
except for those that included gender and apprehension of having a panic attack. Residuals were 
not normalized even after transformations and thus are not reported. Models were fitted using 
maximum likelihood to use all available data (Snijders & Bosker, 2012). Random effects of 
intercept were included in all models. 
According to guidelines for moderation analyses, putative moderators should not be 
related to treatment group (Kraemer et al., 2002). Individuals who received PCT were 
significantly older (M = 38.10, SD = 9.36) than those who received PCT + IV (M = 32.33, SD = 
9.86), t(62) = -2.40, p = .02. Consequently, age was not tested as a moderator. Age was included 
as a covariate for analyses that included frequency of panic attacks because of significant 
negative relationships between age and frequency at post-treatment, rs(48) = -.35, p = .02 and 6-
month follow-up, rs(38) = -.33, p = .04. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 Interoceptive avoidance and fear: 16% shared variance, rs(66) = .40  
  Panic booth avoidance and fear: 31% shared variance, rs(63) = .56  
  Diagnostician-rated in vivo avoidance and fear: 74% shared variance, rs(63) = .86.	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Per Schneider et al. (2015) recommendation, we tested both quadratic (i.e., non-linear) 
and linear effects of moderators. We conducted tests in the following order until one was 
statistically significant (p < .05) or all tests had been conducted: (a) interaction of quadratic 
moderator (i.e., moderator2) × group × time, (b) moderator2 × group (time = covariate), (c) 
moderator × group × time, (d) moderator × group (time = covariate), (e) predictor × time (group 
= covariate), (f) predictor (group & time = covariates). Tests of instantaneous slope were 
conducted for quadratic models and tests of simple slopes for linear models. Bonferroni 
corrections were used for tests of simple effects and slopes in analyses related to demographic 
and clinical characteristics because of the lack of theory behind those analyses. 
Cohen’s f2, a measure of effect size, was calculated for all statistically significant models 
using the method described by Selya, Rose, Dierker, Hedeker, and Mermelstein (2012). Reduced 
models included all covariates, main effects, and lower order interactions, whereas full models 
also included the higher order interaction. Cohen’s f2 of 0.02, 0.15, and 0.35 are considered 
small, medium, and large effect sizes (Cohen, 1988).  
To calculate post hoc power, we used G*Power for linear models as an approximation 
because there is no statistical software for multi-level repeated designs (Faul, Erdfelder, Lang, & 
Buchner, 2007). The power to detect a large effect size (f2 = 0.35) ranged from .90 to 1.00, 
medium (f2 = 0.15) from .49 to .91, small to medium (f2 = 0.085) from .27 to .65, and small (f2 = 
0.02) from .09 to .17; thus, we were sufficiently powered to detect large and potentially medium 
effect sizes and underpowered for smaller ones.6 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 To calculate a range of power, we used the smallest and largest number of predictors (5 for 
analyses that included a predictor without time and 9 for analyses that included a quadratic 
moderator without time). We also used the sample size of 66 and a less conservative size of 117 
that takes into consideration the added benefit of a repeated measures design. To calculate the 
sample size correcting for the design effect we used the equation: design effect = 1 + (n-1)ρI, 
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Results 
As reported in Craske et al. (2003), treatments did not differ significantly at post-
treatment or 6-month follow-up on any outcome measures (i.e., frequency of panic attacks per 
month, apprehension of having a panic attack, avoidance/ fear of interoceptive tasks, avoidance/ 
fear of panic booth, diagnostician-rated in vivo avoidance, severity of agoraphobia, functioning). 
Interoceptive Avoidance and Fear 
Controlling for interoceptive fear, interoceptive avoidance did not moderate panic 
disorder outcomes, ps > .05. Controlling for interoceptive avoidance, interoceptive fear 
significantly interacted with group to moderate apprehension of having a panic attack, z = -2.21, 
SE = 0.25, p = .03, 95% CI [-1.03, -0.06], f2 = 0.07 (see Figure 1). Individuals who reported 
more interoceptive fear (i.e., 2 SD above the mean) had 2.49 units fewer in apprehension of 
having a panic attack after PCT than PCT + IV, z = 2.49, SE = 1.01, p = .014, 95% CI [0.40, 
4.48]. Moreover, individuals who reported the maximum interoceptive fear (8) had 2.85 units 
fewer in apprehension of having a panic attack after PCT than PCT + IV, z = 2.85, SE = 1.16, p 
= .014, 95% CI [0.57, 5.13]. The slope of the PCT group was negative, z = -2.20, SE = 0.20, p = 
.03, 95% CI [-0.82, -0.05], whereas the slope of the PCT + IV group was not significantly 
different from zero, p = .51. This reveals that individuals with greater interoceptive fear 
benefitted more from PCT than PCT + IV. Interoceptive fear did not moderate other panic 
disorder outcomes (i.e., frequency of panic attack, CSR).  
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
where n = the number of time points (i.e., 2) and ρI =  intraclass correlation (Snijders & Bosker, 
2012). We used the smaller intraclass correlation from our analyses, which was .13 and we set 
alpha at .05. 
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Figure 1. Baseline interoceptive fear significantly interacted with group to moderate 
apprehension of having a panic attack. 
 
 
 
Panic Booth Avoidance and Fear 
Controlling for panic booth fear, panic booth avoidance significantly interacted with 
group to moderate agoraphobia CSR, z = 2.23, SE = 0.11, p = .03, 95% CI [0.03, 0.44], f2 = 0.10 
(see Figure 2). Individuals who displayed more panic booth avoidance (i.e., 1 SD below the 
mean duration) had 1.70 greater CSR after PCT + IV than PCT, z = 3.01, SE = 0.50, p = .003, 
95% CI [0.52, 2.48]. There were no group differences at the mean or at the maximum duration, 
ps > .05. The slope of the PCT group was not significantly different from zero, p = .64, whereas 
the slope of the PCT + IV group was negative, z = -3.18, SE = 0.06, p = .001, 95% CI [-0.31, -
0.07]. This reveals that individuals with greater panic booth avoidance benefited more from PCT 
than PCT + IV.  
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Figure 2. Baseline panic booth avoidance significantly interacted with group to moderate 
agoraphobia clinical severity rating. 
 
 
 
Controlling for panic booth avoidance, panic booth fear significantly interacted with 
group to moderate agoraphobia CSR, z = -2.81, SE = 0.14, p = .01, 95% CI [-0.65, -0.11], f2 = 
0.14 (see Figure 3). Individuals who reported more panic booth fear (i.e., 1 SD above the mean) 
had 1.45 greater CSR after PCT + IV than PCT, z = 3.38, SE = 0.43, p = .001, 95% CI [0.61, 
2.30]. There were no group differences at 1 SD below the mean or at the mean, ps > .05. The 
slope of the PCT group was not significantly different from zero, p = .50, whereas the slope of 
the PCT + IV group was positive, z = 3.54, SE = 0.08, p < .001, 95% CI [0.13, 0.47]. This 
reveals that individuals with greater panic booth fear benefitted more from PCT than PCT + IV. 
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Figure 3. Baseline panic booth fear significantly interacted with group to moderate agoraphobia 
clinical severity rating. 
 
 
 
Demographic and Clinical Characteristics  
Gender significantly interacted with time to predict the frequency of panic attacks, F(7, 
43) = 2.86, p = .02, f2 = 0.10 (see Figure 4). Adjusting for multiple comparisons, tests of simple 
effects revealed that at 6-month follow-up, females had 0.71 units less in frequency of panic 
attacks than males, t = 2.50, SE = 0.28, p = .016, 95% CI [0.14, 1.28]. There was no significant 
difference between females and males at post-treatment, p = .98. There were also no significant 
differences within females and within males at each time point, ps > .017. 
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Figure 4. Gender significantly interacted with group to moderate apprehension of having a panic 
attack.  
 
 
 
The quadratic term of duration since first panic attack significantly interacted with group 
to moderate apprehension of having a panic attack, z = 2.06, SE = 0.004, p = .04, 95% CI 
[0.0004, 0.02] (see Figure 5). Adjusting for multiple comparisons, tests of simple effects 
revealed no significant group differences in apprehension at the mean, minimum, and 1 SD 
above the mean, ps > .017. We tested the minimum because 1 SD below the mean was outside 
the possible range. Considering there were no significant differences at these values, we added 
post hoc tests of simple effects at 2 SD above the mean and maximum score for a total of five 
tests. Adjusting for multiple comparisons, tests of simple effects revealed no significant group 
differences in apprehension, ps > .01. Given these results, we did not conduct tests of 
instantaneous slopes nor did we calculate effect sizes.  
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Figure 5. Baseline duration since first panic attack significantly interacted with group to 
moderate agoraphobia clinical severity rating. 
 
 
 
Discussion 
 Primary outcomes from this study revealed that PCT and PCT + IV did not differ 
significantly in terms of efficacy for panic disorder with or without agoraphobia (Craske et al., 
2003). To improve treatment outcomes, we investigated whether certain types of individuals did 
better overall and whether one treatment was better suited for certain types of individuals than 
the other. We hypothesized that individuals with more baseline interoceptive avoidance 
(compared to individuals with less baseline interoceptive avoidance) would benefit more from 
PCT than PCT + IV because it would target their deficit. Correspondingly, we hypothesized that 
individuals with more baseline in vivo avoidance (compared to individuals with less baseline in 
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vivo avoidance) would benefit more from the PCT + IV than PCT. We also tested interoceptive 
fear, in vivo fear, clinical characteristics, and demographic factors as predictors and moderators.  
Baseline interoceptive avoidance did not moderate panic disorder outcomes; however, 
interoceptive fear moderated apprehension of having a panic attack, such that individuals with 
greater fear (+2 SD) had less apprehension following PCT than PCT + IV. Contrary to our 
hypothesis, individuals with high baseline in vivo avoidance and fear (+1 SD) on the panic booth 
task had higher agoraphobia CSR following PCT + IV compared to PCT. The effect sizes for the 
aforementioned results ranged from 0.07 to 0.14.7 Time did not interact with any of the 
moderators, suggesting that moderation effects continue through 6-month follow-up.  
Overall, individuals with higher interoceptive fear, panic booth avoidance, and panic 
booth fear fared better in PCT than PCT + IV compared to individuals with lower avoidance and 
fear. One explanation for these results is that highly phobic and avoidant individuals benefit from 
concentrated doses of exposure to their primary interoceptive concerns. They may be avoiding 
the panic booth because of fear of their bodily sensations. Indeed, panic disorder was the 
principal diagnosis for all participants. In line with the notion that a single focused treatment is 
more beneficial than a treatment that aims to address multiple targets, we previously found that 
individuals randomized to group CBT for primary diagnoses of panic disorder and agoraphobia 
did better than individuals randomized to group CBT that also targeted comorbid anxiety 
disorders (Craske et al., 2007). On the other hand, in a study of 25 individuals with comorbid 
panic disorder and generalized anxiety disorder (GAD), there were no group differences between 
individuals who were randomized to receive CBT for their primary diagnosis and those who 
were randomized to receive CBT for both panic disorder and GAD (Primiano et al., 2014). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7	  Cohen’s f2 of 0.02 and 0.15 are considered small and medium, respectively (Cohen, 1988).	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Nevertheless, the study was likely underpowered to detect group differences because of the small 
sample size.  
 Another possible explanation for why individuals who have high interoceptive fear, panic 
booth avoidance, and panic booth fear benefit more from PCT than PCT + IV is that the 
repetition of treatment in the PCT group provides individuals with an opportunity to develop a 
greater sense of mastery of treatment material, or greater opportunity to evaluate their progress. 
Individuals with high panic booth avoidance and fear may do worse in PCT + IV than PCT 
because eight sessions of in vivo treatment may not be enough to decrease their in vivo 
avoidance and fear, leaving them to feel as though they have not/ or cannot improve. It is also 
possible that the repetition of treatment in the PCT group afforded individuals the chance to 
engage in a larger variety of interoceptive exposures, thereby enhancing extinction learning, 
compared to those in the PCT + IV group. Unfortunately, we did not include session-by-session 
measures, nor did we include measures of perceived mastery or progress to test these hypotheses.  
Contrary to our hypotheses, interoceptive avoidance did not moderate any outcome 
measures. One explanation may be that our measure of interoceptive avoidance is limited 
because it does not capture response to unexplained physiological sensations. Additionally, 
interoceptive fear only moderated one of three panic disorder outcome measures. Moreover, 
panic booth avoidance and fear moderated outcomes, whereas diagnostician-rated avoidance and 
fear did not. This implies that the results are specific to panic booth avoidance rather than to in 
vivo avoidance of many different places. Alternatively, these results could suggest that 
diagnosticians may not be particularly accurate at judging levels of participants’ behavioral 
avoidance. The conjecture that panic booth avoidance and diagnostician-rated avoidance are 
measuring different concepts is somewhat supported by the weak relationship between the two 
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measures, which we have reported in this paper’s Method section under the “in vivo avoidance 
and fear” heading. Indeed, diagnostician ratings of avoidance are dependent on patient self-report 
which have been found to be discrepant from actual avoidance in laboratory paradigms (Gamez, 
Kotov, & Watson, 2010; McNeil, Ries, & Turk, 1995). Similar to our current findings, in a study 
on moderators of behavioral therapy for social anxiety disorder, we found that behavioral 
avoidance measured on a public speaking task was a significant moderator of outcomes, but 
avoidance measured via diagnostician rating was not a significant moderator (Mesri et al., 2017). 
Lastly, some results may have been non-significant simply because they were underpowered.  
As for clinical and demographic characteristics, females had less frequent panic attacks 
than males by 6-month follow-up. Additionally, the quadratic term of duration since first panic 
attack was a significant moderator of agoraphobia CSR. Despite a statistically significant model, 
tests of simple effects revealed only one group difference at 1 SD above the mean.  
Overall, our findings provide additional data in the investigation of predictors and 
moderators of treatment outcomes. Some strengths of the study include using behavioral 
measures of avoidance rather than reliance on self-report and statistically controlling for 
avoidance and fear to isolate the effects of each. Our use of group therapy is both a strength and 
limitation of the study; group CBT is well validated for panic disorder and uses fewer resources 
per individual than traditional one-on-one therapy, but it limits our generalizability to other 
formats of CBT (Butler, Chapman, Forman, & Beck, 2006; Schwartze et al., 2017). Inclusion 
and exclusion criteria for the study further limit generalizability. Other limitations include a 
small and largely Caucasian sample, low power, and lack of participant details through each 
phase of the study. The lack of self-report measures is also limiting because the ADIS-IV ratings 
are fairly restricted and could have limited our ability to detect differences between the 
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groups. Future studies should consider including longer follow-up intervals, using composite 
measures, and keeping records of the number and type of exposures that participants conducted 
in/ between session to better understand these effects. The results are limited, but nonetheless 
raise the possibility that avoidance and fear can be used as prescriptive factors for treatment 
matching and personalized care.  
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DISSERTATION DISCUSSION 
This dissertation is a series of three studies that applies theoretical knowledge of 
avoidance to improve treatment efficacy for individuals with anxiety disorders. Avoidance is 
posited to maintain anxiety by blocking extinction learning, and exposure therapy is posited to 
treat anxiety by targeting that avoidance (Lerman, 2003). In study 1, we test whether retraining 
implicit avoidance can augment extinction learning and decrease avoidance behavior. In studies 
2 and 3, we investigate whether avoidant individuals benefit more from one therapy or another. 
In study 1, we hypothesized that training implicit approach to feared stimuli would (1) 
enhance fear extinction and (2) promote approach to feared stimuli, by increasing the salience of 
the stimuli during extinction learning. Results revealed that training implicit approach or 
avoidance of feared stimui did not affect fear extinction or future avoidance behavior. Baseline 
explicit avoidance also did not affect fear extinction, but it did affect future avoidance behavior, 
such that individuals who reported as highly avoidant at baseline were more likely to avoid 
feared stimuli at the end of the study compared to individuals who were reported as less 
avoidant. We did not find an effect of retraining implicit biases in an unambiguous fear 
conditioning design, but these results could change under difference circumstances (e.g., more 
power, ambiguous fear conditioning design).  
  In study 2, we investigated whether individuals with baseline avoidance fare better in one 
of two behavioral therapies (CBT, ACT) for social anxiety disorder. Both CBT and ACT target 
avoidance; however, CBT more explicitly targets behavioral avoidance, whereas ACT more 
specifically targets experiential avoidance. From a deficit correction model, we hypothesized that 
individuals who are more behaviorally avoidant at baseline would benefit more from CBT than 
ACT (compared to individuals who are less avoidant) because CBT more systematically targets 
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that type of avoidance. Behavioral avoidance was measured in two ways (1) in vivo avoidance of 
a public speaking task and (2) clinician rating of 14 social situations. Results revealed that 
individuals who were highly avoidant of the baseline public speaking task fared better by 12-
month follow-up after CBT than ACT compared to individuals who were less avoidant at 
baseline. Conversely, clinician-rated social avoidance did not moderate outcome, suggesting that 
the results are specific to public speaking avoidance versus general social avoidance. 
Alternatively, the divergent findings may be a result of low power. Despite limitations, this study 
suggests that baseline avoidance can play a prescriptive role in matching treatments to 
individuals. 
 Seeing as avoidance was a significant moderator of treatment outcome in social anxiety 
disorder, in study 3, we attempt to replicate and expand those findings by investigating 
avoidance as a treatment moderator for panic disorder. We tested whether individuals with 
baseline interoceptive and in vivo avoidance benefit more from one of two treatments for panic 
disorder: (1) CBT with interoceptive exposures or (2) CBT with mixed exposures (i.e., 
interoceptive and in vivo exposures). From a deficit correction perspective and in line with 
previous findings (e.g., study 2), we hypothesized that individuals with more interoceptive 
avoidance would benefit more from CBT with interoceptive exposures than CBT with mixed 
exposures, compared to individuals with less interoceptive avoidance. Additionally, we 
hypothesized that individuals with more in vivo avoidance would benefit more from CBT with 
mixed exposures than CBT with interoceptive exposures, compared to individuals with less in 
vivo avoidance. Contrary to our hypotheses, individuals who displayed more in vivo avoidance 
at baseline benefitted more from CBT with interoceptive exposures than CBT with mixed 
exposures compared to individuals with less in vivo avoidance. Interoceptive avoidance did not 
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moderate outcome. This suggests that individuals with panic disorder who have high in vivo 
avoidance benefit more from exposures to their main interoceptive concerns as opposed to 
exposures to both interoceptive and in vivo avoidance. This study provides additional support for 
using baseline avoidance for clinical decision-making when treatment planning.   
Strengths across all three studies include measuring different types of avoidance (e.g., 
implicit, explicit, interoceptive, in vivo) using a range of methods (e.g., behavioral, self-report, 
clinician-rated). In both studies 2 and 3, behavioral measures of avoidance moderated outcome, 
but clinician-rated avoidance did not. As mentioned before, it is possible that null findings were 
because of low power or other reasons. Nevertheless, we are interested in whether this effect is 
replicated in other studies. If so, it may suggest that clinician-rated avoidance is not as useful in 
treatment prescription than behavioral avoidance. Instead of interviewing patients to rate their 
level of avoidance, clinicians may want to ask their patients to stand up and engage in a 
behavioral task. This behavioral measure may be more ecologically valid than clinician 
interviews, which rely partly on patient report. 
 Taken together, this dissertation highlights the important role of avoidance as a 
maintenance factor and potential prescriptive factor in anxiety disorders. Improving our ability to 
prescribe treatments can enhance treatment response. Moreover, research in this area also helps 
expand our theoretical understanding of anxiety, avoidance, and behavioral treatments. 
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Appendix 
Brief Clinician Protocol for Assessing Public Speaking Avoidance 
 
“I would like you to give a 3-minute speech while standing up. I will be observing you and may 
also videotape you in order to evaluate the speech on content and delivery later. I would like you 
to talk about global warming and/or corporeal punishment. You can talk about one or both of the 
topics. I will give you 5 minutes to prepare your speech.  You can write notes on a piece of paper 
but you cannot use the paper when you are speaking.”   
 
 
GIVE PATIENT PEN AND NOTEPAD 
 
 
 
AFTER 5 MINUTES, ASK PATIENT TO STAND AND GIVE THE SPEECH. TIME 
THE PATIENT. 
 
After 3 minutes have elapsed say:  “Would you be willing to continue speaking?  You may 
continue for any amount of time up to 3 minutes.  It’s up to you.  Would you like to continue 
speaking?” 
 
Record duration of speech. 
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